JPH0451527B2 - - Google Patents
Info
- Publication number
- JPH0451527B2 JPH0451527B2 JP57006085A JP608582A JPH0451527B2 JP H0451527 B2 JPH0451527 B2 JP H0451527B2 JP 57006085 A JP57006085 A JP 57006085A JP 608582 A JP608582 A JP 608582A JP H0451527 B2 JPH0451527 B2 JP H0451527B2
- Authority
- JP
- Japan
- Prior art keywords
- spiro
- imidazolidine
- dione
- compound
- chroman
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 claims description 77
- 206010012601 diabetes mellitus Diseases 0.000 claims description 35
- 230000001684 chronic effect Effects 0.000 claims description 26
- 208000024891 symptom Diseases 0.000 claims description 26
- 239000003795 chemical substances by application Substances 0.000 claims description 16
- 150000003839 salts Chemical class 0.000 claims description 16
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 15
- -1 6-bromo-2,2-dimethyl-spiro-[chroman-4,4'-imidazolidine] Chemical compound 0.000 claims description 14
- 125000000217 alkyl group Chemical group 0.000 claims description 13
- 206010007749 Cataract diabetic Diseases 0.000 claims description 10
- 201000007025 diabetic cataract Diseases 0.000 claims description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 9
- 208000032131 Diabetic Neuropathies Diseases 0.000 claims description 9
- 125000003545 alkoxy group Chemical group 0.000 claims description 7
- 230000003449 preventive effect Effects 0.000 claims description 7
- 230000001225 therapeutic effect Effects 0.000 claims description 7
- 125000005843 halogen group Chemical group 0.000 claims description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 6
- 238000011282 treatment Methods 0.000 claims description 6
- 229910052799 carbon Inorganic materials 0.000 claims description 5
- 150000001469 hydantoins Chemical class 0.000 claims description 5
- 230000002265 prevention Effects 0.000 claims description 4
- 125000004429 atom Chemical group 0.000 claims description 3
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 3
- 229910052717 sulfur Inorganic materials 0.000 claims description 3
- 125000004434 sulfur atom Chemical group 0.000 claims description 3
- NEPZYDYDQCRIHX-UHFFFAOYSA-N 6,8-dichloro-2,2-dimethylspiro[3h-chromene-4,5'-imidazolidine]-2',4'-dione Chemical compound C12=CC(Cl)=CC(Cl)=C2OC(C)(C)CC21NC(=O)NC2=O NEPZYDYDQCRIHX-UHFFFAOYSA-N 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims description 2
- 150000001721 carbon Chemical group 0.000 claims 2
- 229940124374 agent for diabetic neuropathy Drugs 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 description 23
- 239000013078 crystal Substances 0.000 description 23
- 238000003786 synthesis reaction Methods 0.000 description 22
- 208000002177 Cataract Diseases 0.000 description 17
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 16
- 238000002844 melting Methods 0.000 description 16
- 230000008018 melting Effects 0.000 description 16
- 238000000034 method Methods 0.000 description 16
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 15
- 230000000694 effects Effects 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 238000009825 accumulation Methods 0.000 description 13
- 201000010099 disease Diseases 0.000 description 13
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 12
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 239000000600 sorbitol Substances 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 10
- 210000000695 crystalline len Anatomy 0.000 description 10
- 230000002401 inhibitory effect Effects 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 230000005764 inhibitory process Effects 0.000 description 9
- MVGNILTYCLILSK-UHFFFAOYSA-N 6-chloro-2,2-dimethylspiro[3h-chromene-4,5'-imidazolidine]-2',4'-dione Chemical compound C12=CC(Cl)=CC=C2OC(C)(C)CC21NC(=O)NC2=O MVGNILTYCLILSK-UHFFFAOYSA-N 0.000 description 8
- 241000700159 Rattus Species 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 229930182830 galactose Natural products 0.000 description 8
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 8
- 210000003497 sciatic nerve Anatomy 0.000 description 8
- 102000016912 Aldehyde Reductase Human genes 0.000 description 7
- 108010053754 Aldehyde reductase Proteins 0.000 description 7
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 7
- 206010012689 Diabetic retinopathy Diseases 0.000 description 7
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 6
- 239000001099 ammonium carbonate Substances 0.000 description 6
- 235000012501 ammonium carbonate Nutrition 0.000 description 6
- 238000007796 conventional method Methods 0.000 description 6
- SEAQTHCVAGBRFY-UHFFFAOYSA-N 6-fluoro-2-methylspiro[2,3-dihydrochromene-4,5'-imidazolidine]-2',4'-dione Chemical compound C12=CC(F)=CC=C2OC(C)CC21NC(=O)NC2=O SEAQTHCVAGBRFY-UHFFFAOYSA-N 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 238000000921 elemental analysis Methods 0.000 description 5
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 208000019553 vascular disease Diseases 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 4
- 208000033679 diabetic kidney disease Diseases 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 201000001119 neuropathy Diseases 0.000 description 4
- RGSFGYAAUTVSQA-UHFFFAOYSA-N pentamethylene Natural products C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 229940124597 therapeutic agent Drugs 0.000 description 4
- OAQBJKPCYZKZJH-UHFFFAOYSA-N 6-chloro-2,2-dimethyl-3h-chromen-4-one Chemical compound ClC1=CC=C2OC(C)(C)CC(=O)C2=C1 OAQBJKPCYZKZJH-UHFFFAOYSA-N 0.000 description 3
- LFNSMJIWORQTOV-UHFFFAOYSA-N 6-chloro-2-methylspiro[2,3-dihydrochromene-4,5'-imidazolidine]-2',4'-dione Chemical compound C12=CC(Cl)=CC=C2OC(C)CC21NC(=O)NC2=O LFNSMJIWORQTOV-UHFFFAOYSA-N 0.000 description 3
- RPAIBTVEPAACRP-UHFFFAOYSA-N 6-fluoro-2-methyl-2,3-dihydrochromen-4-one Chemical compound FC1=CC=C2OC(C)CC(=O)C2=C1 RPAIBTVEPAACRP-UHFFFAOYSA-N 0.000 description 3
- 229920002261 Corn starch Polymers 0.000 description 3
- 208000002249 Diabetes Complications Diseases 0.000 description 3
- 206010012655 Diabetic complications Diseases 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 229940053195 antiepileptics hydantoin derivative Drugs 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000008120 corn starch Substances 0.000 description 3
- 229940099112 cornstarch Drugs 0.000 description 3
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 206010062198 microangiopathy Diseases 0.000 description 3
- 229920000137 polyphosphoric acid Polymers 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 239000013076 target substance Substances 0.000 description 3
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 3
- IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical compound C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 description 2
- YULGYUXEAKRUNW-UHFFFAOYSA-N 5-chloro-2,2-dimethyl-1-benzofuran-3-one Chemical compound C1=C(Cl)C=C2C(=O)C(C)(C)OC2=C1 YULGYUXEAKRUNW-UHFFFAOYSA-N 0.000 description 2
- USFKUIJPHNSYGN-UHFFFAOYSA-N 6-chloro-2-methyl-2,3-dihydrochromen-4-one Chemical compound ClC1=CC=C2OC(C)CC(=O)C2=C1 USFKUIJPHNSYGN-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 206010010356 Congenital anomaly Diseases 0.000 description 2
- 208000027472 Galactosemias Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 206010024214 Lenticular opacities Diseases 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 206010029240 Neuritis Diseases 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000003288 aldose reductase inhibitor Substances 0.000 description 2
- 229940090865 aldose reductase inhibitors used in diabetes Drugs 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 229940127003 anti-diabetic drug Drugs 0.000 description 2
- 239000003472 antidiabetic agent Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 201000008383 nephritis Diseases 0.000 description 2
- 230000007823 neuropathy Effects 0.000 description 2
- 208000033808 peripheral neuropathy Diseases 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 2
- 229960001052 streptozocin Drugs 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 230000000451 tissue damage Effects 0.000 description 2
- 231100000827 tissue damage Toxicity 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- XTGCUDZCCIRWHL-UHFFFAOYSA-N 1-(5-chloro-2-hydroxyphenyl)ethanone Chemical compound CC(=O)C1=CC(Cl)=CC=C1O XTGCUDZCCIRWHL-UHFFFAOYSA-N 0.000 description 1
- MGKPCLNUSDGXGT-UHFFFAOYSA-N 1-benzofuran-3-one Chemical compound C1=CC=C2C(=O)COC2=C1 MGKPCLNUSDGXGT-UHFFFAOYSA-N 0.000 description 1
- YNPDFBFVMJNGKZ-UHFFFAOYSA-N 2'-Hydroxy-5'-methylacetophenone Chemical compound CC(=O)C1=CC(C)=CC=C1O YNPDFBFVMJNGKZ-UHFFFAOYSA-N 0.000 description 1
- SZCYUFPFQGHOMZ-UHFFFAOYSA-N 2,2-dimethyl-3h-cyclopenta[b]pyran Chemical compound O1C(C)(C)CC=C2C=CC=C21 SZCYUFPFQGHOMZ-UHFFFAOYSA-N 0.000 description 1
- SVBTVWFAWUFLGV-UHFFFAOYSA-N 2-bromo-1-(5-chloro-2-hydroxyphenyl)-2-methylpropan-1-one Chemical compound CC(C)(Br)C(=O)C1=CC(Cl)=CC=C1O SVBTVWFAWUFLGV-UHFFFAOYSA-N 0.000 description 1
- NCDSEQNSIBPEKG-UHFFFAOYSA-N 2-methyl-2,3-dihydrochromen-4-one Chemical compound C1=CC=C2OC(C)CC(=O)C2=C1 NCDSEQNSIBPEKG-UHFFFAOYSA-N 0.000 description 1
- WPWNEKFMGCWNPR-UHFFFAOYSA-N 3,4-dihydro-2h-thiochromene Chemical compound C1=CC=C2CCCSC2=C1 WPWNEKFMGCWNPR-UHFFFAOYSA-N 0.000 description 1
- MSTDXOZUKAQDRL-UHFFFAOYSA-N 4-Chromanone Chemical compound C1=CC=C2C(=O)CCOC2=C1 MSTDXOZUKAQDRL-UHFFFAOYSA-N 0.000 description 1
- VZXOZSQDJJNBRC-UHFFFAOYSA-N 4-chlorobenzenethiol Chemical compound SC1=CC=C(Cl)C=C1 VZXOZSQDJJNBRC-UHFFFAOYSA-N 0.000 description 1
- RHMPLDJJXGPMEX-UHFFFAOYSA-N 4-fluorophenol Chemical compound OC1=CC=C(F)C=C1 RHMPLDJJXGPMEX-UHFFFAOYSA-N 0.000 description 1
- ISHSYOKGQZKLNP-UHFFFAOYSA-N 5-chloro-2,2-dimethylspiro[1-benzofuran-3,5'-imidazolidine]-2',4'-dione Chemical compound CC1(C)OC2=CC=C(Cl)C=C2C11NC(=O)NC1=O ISHSYOKGQZKLNP-UHFFFAOYSA-N 0.000 description 1
- FPMXLCAGUDHBRV-UHFFFAOYSA-N 5-chloro-2-methyl-1-benzofuran-3-one Chemical compound C1=C(Cl)C=C2C(=O)C(C)OC2=C1 FPMXLCAGUDHBRV-UHFFFAOYSA-N 0.000 description 1
- RSDMRIAHZVMNKC-UHFFFAOYSA-N 5-fluoro-2,2-dimethylspiro[1-benzofuran-3,5'-imidazolidine]-2',4'-dione Chemical compound CC1(C)OC2=CC=C(F)C=C2C11NC(=O)NC1=O RSDMRIAHZVMNKC-UHFFFAOYSA-N 0.000 description 1
- OBZVMLSDZOMNRM-UHFFFAOYSA-N 6-bromo-2,2-dimethylspiro[3h-chromene-4,5'-imidazolidine]-2',4'-dione Chemical compound C12=CC(Br)=CC=C2OC(C)(C)CC21NC(=O)NC2=O OBZVMLSDZOMNRM-UHFFFAOYSA-N 0.000 description 1
- NNOKTEYBUWSOCV-UHFFFAOYSA-N 6-chloro-2-methyl-2,3-dihydrothiochromen-4-one Chemical compound ClC1=CC=C2SC(C)CC(=O)C2=C1 NNOKTEYBUWSOCV-UHFFFAOYSA-N 0.000 description 1
- KHUIZUAGKLRWQU-UHFFFAOYSA-N 6-fluoro-2,2-dimethylspiro[3h-thiochromene-4,5'-imidazolidine]-2',4'-dione Chemical compound C12=CC(F)=CC=C2SC(C)(C)CC21NC(=O)NC2=O KHUIZUAGKLRWQU-UHFFFAOYSA-N 0.000 description 1
- LXANPKRCLVQAOG-UHFFFAOYSA-N 6-fluorospiro[2,3-dihydrochromene-4,5'-imidazolidine]-2',4'-dione Chemical compound C12=CC(F)=CC=C2OCCC21NC(=O)NC2=O LXANPKRCLVQAOG-UHFFFAOYSA-N 0.000 description 1
- MKRFQNHWYOFEGN-UHFFFAOYSA-N 7-chloro-2-methylspiro[2,3-dihydrochromene-4,5'-imidazolidine]-2',4'-dione Chemical compound C12=CC=C(Cl)C=C2OC(C)CC21NC(=O)NC2=O MKRFQNHWYOFEGN-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 206010016818 Fluorosis Diseases 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- SUAKHGWARZSWIH-UHFFFAOYSA-N N,Nâdiethylformamide Chemical compound CCN(CC)C=O SUAKHGWARZSWIH-UHFFFAOYSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 150000001323 aldoses Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 159000000032 aromatic acids Chemical class 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 1
- 229940084030 carboxymethylcellulose calcium Drugs 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 150000004292 cyclic ethers Chemical class 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- DLFVBJFMPXGRIB-UHFFFAOYSA-M ethanimidate Chemical compound CC([O-])=N DLFVBJFMPXGRIB-UHFFFAOYSA-M 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- MNQZXJOMYWMBOU-UHFFFAOYSA-N glyceraldehyde Chemical compound OCC(O)C=O MNQZXJOMYWMBOU-UHFFFAOYSA-N 0.000 description 1
- 150000002357 guanidines Chemical class 0.000 description 1
- 229940083094 guanine derivative acting on arteriolar smooth muscle Drugs 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
- 239000001341 hydroxy propyl starch Substances 0.000 description 1
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- IMACFCSSMIZSPP-UHFFFAOYSA-N phenacyl chloride Chemical compound ClCC(=O)C1=CC=CC=C1 IMACFCSSMIZSPP-UHFFFAOYSA-N 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920001289 polyvinyl ether Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 125000003003 spiro group Chemical group 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000000707 stereoselective effect Effects 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Description
æ¬çºæã¯ãããã³ãã€ã³èªå°äœãå«æããæ²»ç
çšè¬å€ã«é¢ãããæŽã«è©³ããè¿°ã¹ãã°ã äžè¬åŒ ïŒåŒäžX1ããã³X2ã¯åäžãŸãã¯ç°ãªã€ãŠãã
ããæ°ŽçŽ ååãããã²ã³ååãäœçŽã¢ã«ãã«åºã
ãŸãã¯äœçŽã¢ã«ã³ãã·åºãæå³ããã¯é žçŽ åå
ãŸãã¯ç¡«é»ååãæå³ããR1ããã³R2ã¯åäžãŸ
ãã¯ç°ãªã€ãŠããããæ°ŽçŽ ååãäœçŽã¢ã«ãã«
åºãããšãã«åºããŸãã¯äž¡è ãšãããã«çµåããŠ
ããççŽ ååãšã§ç°ã圢æãããäœããR1ãã
ã³R2ãåæã«æ°ŽçŽ ååã§ããå Žåã¯é€ããïœã¯
ïŒãŸãã¯ïŒã®æŽæ°ãæå³ãããïŒã§è¡šããããã
ãã³ãã€ã³èªå°äœããã³ãã®å¡©ãæå¹æåãšãã
ç³å°¿ç ã«ãšããªãæ ¢æ§çç¶ã»å䜵çç¶ã®æ²»çã»äº
é²å€ã«é¢ãããã®ã§ããã äžèšäžè¬åŒããã«ãããŠãX1ïŒX2ïŒR1ïŒã
ãã³R2ã®å®çŸ©äžã«ã¿ãããäœçŽã¢ã«ãã«åºãŸã
ã¯äœçŽã¢ã«ã³ãã·åºãšã¯ççŽ æ°ïŒãïŒã®çŽéè¥ã
ãã¯åæç¶ã®ã¢ã«ãã«åºãäŸãã°ã¡ãã«ããšã
ã«ãïœâãããã«ãã€ãœãããã«ãïœâããã«ã
ã€ãœããã«ãtertâããã«ãïœâãã³ãã«ãã€ãœ
ã¢ãã«ãïœâããã·ã«åºãªã©ã®ã¢ã«ãã«åºè¥ãã
ã¯ãããã«åºã¥ãã¢ã«ã³ãã·åºãæå³ããããŸã
X1ããã³X2ã®å®çŸ©äžã«ã¿ãããããã²ã³ååãš
ã¯å ·äœçã«ã¯å¡©çŽ ãèçŽ ããšãŠçŽ ãããçŽ ãæå³
ããããŸããR1ããã³R2ã®å®çŸ©äžã«ã¿ãããäž¡
è ãšãããã«çµåããŠããççŽ ååãšã§ç°ã圢æ
ããå Žåã®äŸãå ·äœçã«è¿°ã¹ãã°ãã·ã¯ããã
ã«ãã·ã¯ããã³ãã«ãã·ã¯ãããã·ã«åºãªã©ãæ
å³ããã æ¬çºæã«ãããŠãã®å¡©ãšã¯ãå»è¬ãšããŠèš±å®¹ã§
ããå¡©ãæå³ããå ·äœçã«ã¯ããããªãŠã ãã«ãª
ãŠã ãã«ã«ã·ãŠã ããã°ãã·ãŠã ãªã©ã®éœã€ãªã³
ãšã®å¡©ãæå³ããã ãŸãæ¬çºæååç©ã¯ããã®æ§é äžïŒãªããïŒå
ã®äžæççŽ ååãæããããïŒåã®ç«äœç°æ§äœã
ããã³ããããã®å åŠç°æ§äœãååšãããããæ¬
çºæã«ãããŠã¯ãããã®ãããããå«ãããšã¯ã
ããŸã§ããªãã æ¬çºæã«ãã€ãŠæäŸãããããã³ãã€ã³èªå°äœ
ã¯ãç³å°¿ç ã«äŒŽãçš®ã ã®æ ¢æ§çç¶ãããªãã¡ãç³
å°¿ç ã®å䜵çããšãã°ç³å°¿ç æ§çœå éãç³å°¿ç æ§
ç¥çµé害ãç³å°¿ç æ§è çãªã©ã®çŽ°å°è¡ç®¡é害ãç³
å°¿ç æ§ç¶²èçãããã³ç³å°¿ç ã«èµ·å ããçš®ã ã®å
è硬åæ§è¡ç®¡é害ïŒå 倩æ§ã¬ã©ã¯ããŒã¹è¡çã«äŒŽ
ãªãçœå éãªã©ã®æ²»çããã³äºé²ã«åªããå¹æã
æããã æ¬çºæã«ãããŠãç³å°¿ç ã«ãšããªãæ ¢æ§çç¶ã»
å䜵çç¶ãšã¯ãäŸãã°ç³å°¿ç æ§çœå éïŒç³å°¿ç æ§
ç¥çµé害ïŒç³å°¿ç æ§è çãŸãã¯ç³å°¿ç æ§ç¶²èçãª
ã©ã®çŽ°å°è¡ç®¡é害ïŒããã³ç³å°¿ç ã«èµ·å ããçš®ã
ã®åè硬åæ§è¡ç®¡é害ïŒå 倩æ§ã¬ã©ã¯ããŒã¹è¡ç
ã«äŒŽãªãçœå éãªã©ãæå³ããããç³å°¿ç ã«èµ·å
ããçŸæ£ã§ããã°ãããããå å«ãããã®ã§ã
ãã åŸæ¥ãã¹ã«ããã«ãŠã¬ã¢å€ãã¡ãŸèé žå¡©å€ãã°
ã¢ããžã³èªå°äœãªã©å€æ°ã®ç³å°¿ç æ²»çè¬ãåžå Žã«
ã ãããŠãããããããã¯éè¡ç³ã«å¯Ÿãã察çç
ãªæ²»çè¬ã§ã決å®çãªç³å°¿ç æ²»çè¬ã¯ãªãã æ®ã«ãç³å°¿ç ã«ãšããªãçš®ã ã®æ ¢æ§çç¶ãå䜵
çç¶ãããšãã°ç³å°¿ç æ§çœå éãç³å°¿ç æ§ç¥çµé
害ãç³å°¿ç æ§ç¶²èçãªã©ã®æ²»çå€ã¯ãã»ãšãã©ãª
ããæå¹ãªæ²»çæ³ã¯å šããªããšãã€ãŠãéèšã§ã¯
ãªãã®ãå®æ ã§ãããæ®ã«æ°Žæ¶äœã®æ··æ¿ã§ããçœ
å éã«ã€ããŠã¯è¬å€ã«ããæå¹ãªæ²»çæ³ã¯ã»ãšã
ã©ãªãã äžèšã®ãããªå®æ ããããã®ãããªé£æ²»æ§çŸæ£
ã«æå¹ãªæ²»çè¬ã®ç 究ãé·å¹Žã«ããã€ãŠãããªã
ããŠããããæªã æåããäŸã¯ã»ãšãã©ãªãã ãã®ç 究ã®äžæ¹åãšããŠã¯ã¢ã«ããŒã¹ ãªãã¯
ã¿ãŒãŒïŒAldose reductaseïŒé»å®³ç©è³ªã®æ¢çŽ¢ã§
ãããããªãã¡ã1973幎J.H.Kinoshitaã
ïŒScienseïŒ182ïŒ1146âïŒïŒ1973ïŒã¯ãç³å°¿ç æ§
çœå éæ£è ã«ãããŠãçŒæ°Žæ¶äœäžã®ã¢ã«ããŒã¹
ãªãã¯ã¿ãŒãŒã®æŽ»æ§ãé«ãŸããæµå ¥ããã°ã«ã³ãŒ
ã¹ãã¬ã©ã¯ããŒã¹ãªã©ã®ç³ããã®é µçŽ ã«ããéå
ãããŠãœã«ãããŒã«ãã¬ã©ã¯ãããŒã«ãªã©ã®ããª
ãªãŒã«ãšãªãããããã®ããªãªãŒã«ã®èç©ãæ°Žæ¶
äœãªã©ã®åºè³ªé害ãèµ·ãäž»ããåå ã§ãããšã®èª¬
ãçºè¡šããããã以æ¥ãã®J.H.Kinoshitaã®çè«
ã«åºã¥ãã¢ã«ããŒã¹ ãªãã¯ã¿ãŒãŒé»å®³ç©è³ªã®æ¢
玢ãåºããããªãããŠããã ããããŠãã¬ã€ã³ããŒãã»ãµãŒãžãšã¹ã¯ç¹å®ã®
ããã³ãã€ã³èªå°äœã«ã¢ã«ããŒã¹ ãªãã¯ã¿ãŒãŒ
é»å®³äœçšãããããšãèŠãåºãïŒç¹èš±å ¬éæå53
幎第53653å·ãªã©ïŒããããã®äžã§ç¹ã«ïœâïŒâã
ã«ãªããŒã¹ãããŒãã¯ããã³âïŒïŒ4â²âã€ãããŸ
ãªãžã³ãâ2â²ïŒ5â²âãžãªã³ïŒäžè¬åãœã«ããã«ïŒ
ãææ¡ãããŠããã æ¬çºæè çããäžè¿°ã®åŠãåŸæ¥å€§å€å°é£ãšãã
ãŠãããã®çš®ã®é£æ²»æ§çŸæ£ãããªãã¡ç³å°¿ç ã«ãš
ããªãçš®ã ã®æ ¢æ§çç¶ãå䜵çç¶ã®æ²»çè¬ã®ç
究ã»éçºãç®çãšããŠãé·å¹Žãšããã¿åçš®ã®ç¡æ°
ã®ååç©ã®æ¢çŽ¢ãããæå¹ãªååç©ã®çºèŠã¯æ¥µã
ãŠå°é£æ§ããããããããããã次ã®äžè¬åŒ ïŒåŒäžX1ããã³X2ã¯åäžãŸãã¯ç°ãªã€ãŠãã
ããæ°ŽçŽ ååãããã²ã³ååãäœçŽã¢ã«ãã«åºã
ãŸãã¯äœçŽã¢ã«ã³ãã·åºãæå³ããã¯é žçŽ åå
ãŸãã¯ç¡«é»ååãæå³ããR1ããã³R2ã¯åäžãŸ
ãã¯ç°ãªã€ãŠããããæ°ŽçŽ ååãäœçŽã¢ã«ãã«
åºãããšãã«åºããŸãã¯äž¡è ãšãããã«çµåããŠ
ããççŽ ååãšã§ç°ã圢æãããäœããR1ãã
ã³R2ãåæã«æ°ŽçŽ ååã§ããå Žåã¯é€ããïœã¯
ïŒãŸãã¯ïŒã®æŽæ°ãæå³ãããïŒã§è¡šããããã
ãã³ãã€ã³èªå°äœãããã®é£æ²»æ§çŸæ£ã«æ¥µããŠæ
å¹ã§ããããšãèŠãåºããæ¬çºæãå®æãããã®
ã§ããã æ¬çºæã«ãã€ãŠæäŸãããååç©çŸ€ã¯ã¢ã«ããŒ
ã¹ ãªãã¯ã¿ãŒãŒé»å®³æŽ»æ§ã極ããŠåŒ·ãã®ã¿ãªã
ããç¹èšãã¹ãããšã¯çäœïŒin vivoïŒã«ãããŠã
é©ãã¹ã匷åãªäœçšãçºæ®ããããšã§ãããæŽã«
æ¬çºæã«ãã€ãŠæäŸãããååç©çŸ€ã¯ãæ¯æ§ã極
ããŠåŒ±ããäžæ¢äœçšçä»ã®äœçšã極ããŠåŒ±ããã
ã®ããšã¯èšåºçã«æäžéã極ããŠå°ãªããŠããã
ãšãæå³ããŠãããæ¬çºæã®é©å¿çã§ããç³å°¿ç
æ§çœå éïŒç³å°¿ç æ§ç¥çµé害ïŒç³å°¿ç æ§ç¶²èçã
ç³å°¿ç æ§è çãªã©ã®çŽ°å°è¡ç®¡é害ïŒããã³ç³å°¿ç
ã«èµ·å ããçš®ã ã®åè硬åæ§è¡ç®¡é害ãªã©ã®ã€ã³
ã¹ãªã³éäŸåæ§çµç¹é害ã«åºã¥ãç³å°¿ç æ ¢æ§ç
ç¶ã»å䜵çç¶ã«ãããŠã¯å¿ ç¶çã«é£ç¶æäžãäœå
ãªããããããšãèæ ®ãããšæ¥µããŠéèŠãªããšã§
ããã ãŸããäžè¿°ã®åŠããã®çš®ã®é£æ²»æ§çŸæ£ã«çŸåšæ²»
çè¬ãã»ãšãã©ãªãããšãããæ¬çºæã«ããåå
ç©ã¯æ¥µããŠäŸ¡å€ã®é«ããã®ã§ããã ãã€ãŠãæ¬çºæã®ç®çã¯ãç³å°¿ç ã«ãšããªãã€
ã³ã¹ãªã³éäŸåæ§çµç¹é害ã«åºã¥ãçš®ã ã®æ ¢æ§ç
ç¶ãå䜵çç¶ãããšãã°ç³å°¿ç æ§çœå éïŒç³å°¿ç
æ§ç¥çµé害ïŒç³å°¿ç æ§ç¶²èçãç³å°¿ç æ§è çãªã©
ã®çŽ°å°è¡ç®¡é害ããã³ç³å°¿ç ã«èµ·å ããçš®ã ã®å
è硬åæ§è¡ç®¡é害ãªã©ã«æå¹ãªæ°èŠè¬å€ãæäŸã
ãã«ããã æ¬çºæååç©ã¯ãçš®ã ã®æ¹æ³ã«ãã€ãŠè£œé ãã
ããããã®ä»£è¡šçãªæ¹æ³ã瀺ãã°æ¬¡ã®ãšããã§ã
ãã ïŒåŒäžX1ïŒX2ïŒR1ïŒR2ïŒïŒ¹ããã³ïœã¯åèšã®
æå³ãæãããïŒ ããªãã¡ãæ¬çºæã®ååç©ã¯ã(1)äžèšã®ãã
åŒã§ç€ºãããååç©ãšã(2)ã·ã¢ã³åãããªãŠã ã
ã·ã¢ã³åã«ãªãŠã ã®åŠãã¢ã«ã«ãªéå±ã·ã¢ã³å
ç©ãããã³(3)çé žã¢ã³ã¢ããŠã ã®äžè ãçž®åãã
ãããšã«ãã補é ãããã æ¬åå¿ã®éçšãã奜ãŸãã溶åªã®äŸãããã
ã°ãã¢ã»ãã«ã¢ããã®åŠãäœçŽã¢ã«ã«ãã¢ããã
ã¡ã¿ããŒã«ããšã¿ããŒã«ããããããŒã«ã®åŠãæ°Ž
ãšæ··åããã¢ã«ã«ããŒã«ããžãªããµã³ããã³ãã
ã©ããããã©ã³ã®åŠãç°ç¶ãšãŒãã«ããšãã¬ã³ã°
ãªã³ãŒã«ãããªã¡ãã¬ã³ã°ãªã³ãŒã«ã®åŠãäœçŽã¢
ã«ãã¬ã³ã°ãªã³ãŒã«ãïŒïŒ®âãžã¡ãã«ãã«ã ã¢
ãããïŒïŒ®âãžãšãã«ãã«ã ã¢ããã®åŠãïŒ
âãžã¢ã«ãã«ã¢ãããªã©ããããããšãã§ã
ãã åå¿ã¯äžèšããåŒã§ç€ºãããåºçºç©è³ªã®éã
ã«ãã€ãŠå·Šå³ããããã奜ãŸãã枩床ãšããŠã¯é
åžž50ã150âã®æž©åºŠã§çŽïŒæéãçŽïŒæ¥éãããª
ãããã åå¿ã«éããäžè¿°ã®åºçºç©è³ª(1)ã(2)ã(3)ã®éç
é¢ä¿ã«ã€ããŠã¯ã奜ãŸããã¯éåžž(1)ã®ååç©ã«å¯Ÿ
ããå°ãªããšããããã«éå°ã®(2)ã®ã¢ã«ã«ãªéå±
ã·ã¢ã³åç©ãããã³(3)ã®çé žã¢ã³ã¢ããŠã ãçšã
ããæ¬çºæã®ç®çç©è³ªããã¯ãåå¿å®çµåŸãé
åžžã®æ¹æ³äŸãã°ãŸãæ°Žã§åå¿æ··åç©ãåžéãã次
ãã§åŸããã氎溶液ã宀枩ã«å·åŽããåŸãé žæ§ã«
ããããšã«ããç®çç©è³ªããã容æã«ååã§ã
ãæ²æ®¿ç©ã®åœ¢ã§åé¢ãããã ç®çç©è³ªããã«ãããŠãR1ããã³R2ã®ãã
ãããæ°ŽçŽ ã§ããïŒâã¢ã眮æèªå°äœã®å Žåã«äž
æççŽ ïŒåã®ååšã«åºã¥ãïŒçš®ã®ç«äœç°æ§äœã®ç
æãäºæ³ãããããæ¬è£œé æ¹æ³ã«ããã°ãäžæ¹ã®
ç°æ§äœãç«äœç¹ç°çåªå¢ãã§è£œé ããããããã
ã®ç°æ§äœãåŸè¿°ãããœã«ãããŒã«èç©æå¶çãªã©
掻æ§ãé«ãã®ã§ããããŠå¥œãŸããæ¹æ³ãšãããã ãã®è£œé æ¹æ³ã«ãããŠåºçºç©è³ªã§ããäžè¬åŒ
ããã®ååç©ã¯çš®ã ã®æ¹æ³ã§è£œé ã§ãããæ¬çº
æã«ãããŠã¯ãããªã補é æ¹æ³ã§è£œé ããããã®
ã§ã䜿çšã§ããããšã¯ãããŸã§ããªãã äŸãã°äžèšã®äžè¬åŒããã«ãããŠãX1ïŒïŒšïŒ
X2ïŒïŒâïŒR1ïŒïŒšïŒR2ïŒCH3ïŒïœïŒïŒïŒïŒ¹ïŒ
ïŒã§ããïŒâãã«ãªãâïŒâã¡ãã«âïŒâã¯ãã
ãã³ã¯ãâãã«ãªãããšããŒã«ãšã¯ããã³é žã
ããªãªã³é žã®ååšäžã§çž®åéç°ãããããšã«ãã
åŸãããããŸãäžè¬åŒããã«ãããŠãX1ïŒïŒšïŒ
X2ïŒïŒâClïŒïœïŒïŒïŒïŒ¹ïŒïŒïŒR1ããã³R2ãã·
ã¯ããããµã³ç°ã圢æããå Žåã§ããïŒâã¯ãã
âïŒâã¹ããâã·ã¯ããããµã³âïŒâã¯ãããã³
ã¯ãïŒâãã€ãããã·âïŒâã¯ããã¢ã»ãããšã
ã³ãšã·ã¯ããããµãã³ãããããªãžã³ãªã©ã®ååš
äžã§çž®åéç°ããããšã«ããåŸãããã ãŸãäžè¬åŒããã«ãããŠãX1ïŒïŒšïŒX2ïŒïŒ
âClïŒïœïŒïŒïŒïŒ¹ïŒïŒïŒR1ïŒR2ïŒCH3ã§ããå Ž
åã§ããïŒâã¯ããâïŒïŒïŒâãžã¡ãã«âïŒâã
ã³ãŸãã©ãã³ã¯ãäŸãã°æ¬¡ã®åå¿åŒã«ããåæã
ããã ãŸãäžè¬åŒããã«ãããŠãX1ïŒïŒšïŒX2ïŒïŒ
âClïŒïœïŒïŒïŒïŒ¹ïŒïŒïŒR1ïŒïŒšïŒR2ïŒCH3ã§ã
ãå Žåã§ããïŒâã¯ããâïŒâã¡ãã«âïŒâãã³
ãŸãã©ãã³ã¯ãäžèšã®ïŒâã¯ããâïŒïŒïŒâãžã¡
ãã«âïŒâãã³ãŸãã©ãã³ã«æºããæ¹æ³ã«ããã
äŸãã°æ¬¡ã®åå¿åŒã«ããåæããã ãŸãäžè¬åŒããã«ãããŠãX1ïŒïŒšïŒX2ïŒïŒ
âClïŒïœïŒïŒïŒïŒ¹ïŒïŒ³ïŒR1ïŒïŒšïŒR2ïŒCH3ã§ã
ãïŒâã¯ããâïŒâã¡ãã«âïŒâããªã¯ãããã³
ã¯ãâã¯ããããªããšããŒã«ãšã¯ããã³é žãã
ãªãªã³é žã®ååšäžã§çž®åéç°ãããããšã«ããåŸ
ãããã æŽã«äžè¬åŒããã«ãããŠX1ïŒïŒšïŒX2ïŒïŒâ
ClïŒïœïŒïŒïŒïŒ¹ïŒïŒïŒR1ïŒïŒšïŒR2ïŒããšãã«åº
ã§ããïŒâã¯ããâïŒâããšãã«âïŒâã¯ããã
ã³ã¯äŸãã°æ¬¡ã®åå¿åŒã«ããåæããã æ¬çºæã®ä»£è¡šçãªååç©ãšããŠã¯äŸãã°ä»¥äžã®
ååç©ããããããã ã»ïŒâãã«ãªãâïŒâã¡ãã«âã¹ããâãã¯ãã
ã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³ ã»ïŒâã¯ããâïŒâã¡ãã«âã¹ããâãã¯ããã³
âïŒïŒ4â²âã€ãããŸãªãžã³ã2â²ïŒ5â²âãžãªã³ ã»ïŒâã¯ããâïŒïŒïŒâãžã¡ãã«âã¹ããâãã¯
ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãž
ãªã³ ã»ïŒâãã«ãªãâïŒïŒïŒâãžã¡ãã«âã¹ããâ
ãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ
5â²âãžãªã³ ã»ïŒâã¯ããâïŒïŒïŒâãžã¡ãã«âã¹ããâãã
ã³ãŸãã©ã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ
5â²âãžãªã³ ã»ïŒâãã«ãªãâïŒïŒïŒâãžã¡ãã«âã¹ããâ
ããã³ãŸãã©ã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ
2â²ïŒ5â²âãžãªã³ ã»ïŒâã¯ããâïŒâã¡ãã«âã¹ããâããã³ãŸã
ã©ã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãª
ã³ ã»ïŒâãã«ãªãâïŒâã¡ãã«âã¹ããâããã³ãŸ
ãã©ã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãž
ãªã³ ã»ïŒâã¡ãã«âïŒïŒïŒâãžã¡ãã«âã¹ããâãã¯
ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãž
ãªã³ ã»ïŒâã¡ããã·âïŒïŒïŒâãžã¡ãã«âã¹ããâ
ãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ
5â²âãžãªã³ ã»ïŒïŒïŒâãžã¯ããâïŒïŒïŒâãžã¡ãã«âã¹ãã
âãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ
5â²âãžãªã³ ã»ïŒâããã¢âïŒïŒïŒâãžã¡ãã«âã¹ããâãã¯
ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãž
ãªã³ ã»ïŒâãã«ãªãâïŒïŒïŒâãžãšãã«âã¹ããâ
ãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ
5â²âãžãªã³ ã»ïŒâã¯ããâïŒâãšãã«âã¹ããâãã¯ããã³
âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³ ã»ïŒâã¯ããâïŒâïœâãããã«âã¹ããâãã¯
ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãž
ãªã³ ã»ïŒâãã«ãªãâïŒâãšãã«âã¹ããâãã¯ãã
ã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³ ã»ïŒâãã«ãªãâïŒâïœâãããã«âã¹ããâ
ãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ
5â²âãžãªã³ ã»ïŒâã¯ããâïŒâã€ãœããã«âã¹ããâãã¯ã
ãã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãª
ã³ ã»ïŒâã¯ããâïŒâã€ãœãããã«âã¹ããâãã¯
ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãž
ãªã³ ã»ïŒâã¯ããâïŒâïœâããã«âã¹ããâãã¯ã
ãã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãª
ã³ ã»ïŒâã¡ããã·âïŒâã¡ãã«âã¹ããâãã¯ãã
ã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³ ã»ïŒâã¯ããâïŒâã¡ãã«âã¹ããâãã¯ããã³
âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³ ã»ïŒâã¡ãã«âïŒâã¡ãã«âã¹ããâãã¯ããã³
âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³ ã»ïŒïŒïŒâãžã¯ããâïŒâã¡ãã«âã¹ããâãã¯
ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãž
ãªã³ ã»ïŒïŒïŒâãžã¡ãã«âã¹ããâãã¯ããã³âïŒïŒ
4â²âã€ãããŸãªãžã³ã2â²ïŒ5â²âãžãªã³ ã»ïŒâã¡ãã«âã¹ããâãã¯ããã³âïŒïŒ4â²âã€
ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³ ã»ïŒïŒïŒâãžã¡ãã«âã¹ããâãããªã¯ããã³â
ïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³ ã»ïŒâã¯ããâïŒâããšãã«âã¹ããâãã¯ãã
ã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³ ã»ïŒâãã«ãªãâïŒâã¡ãã«âã¹ããâãããªã¯
ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãž
ãªã³ ã»ïŒâãã«ãªãâïŒïŒïŒâãžã¡ãã«âã¹ããâ
ãããªã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ
2â²ïŒ5â²ãžãªã³ ã»ïŒâã¯ããâïŒâã¡ãã«âã¹ããâãããªã¯ã
ãã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãª
ã³ ã»ïŒâã¯ããâïŒïŒïŒâãžãšãã«âã¹ããâãã
ãªã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ
5â²âãžãªã³ ã»ïŒâãã«ãªãâïŒïŒïŒâãžã¡ãã«âã¹ããâ
ãããªã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ
2â²ïŒ5â²âãžãªã³ ã»ïŒïŒïŒâãžã¯ããâïŒïŒïŒâãžã¡ãã«âã¹ãã
âãããªã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ
2â²ïŒ5â²âãžãªã³ ã»ïŒâãã«ãªãâïŒâïœâãã³ãã«âã¹ããâ
ãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ
5â²âãžãªã³ ã»ïŒâã¯ããâïŒâïœâããã·ã«âã¹ããâãã¯
ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãž
ãªã³ ã»ã·ã¯ããããµã³ãã¹ããâïŒãâïŒâã¡ãã«â
ã¹ããâãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ã
â2â²ïŒ5â²âãžãªã³ ã»ã·ã¯ããããµã³ãã¹ããâïŒãâïŒâã¯ããâ
ã¹ããâãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ã
â2â²ïŒ5â²âãžãªã³ ã»ã·ã¯ããã³ã¿ã³ãã¹ããâïŒãâïŒâã¯ããâ
ã¹ããâãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ã
â2â²ïŒ5â²âãžãªã³ ã»ã·ã¯ããã³ã¿ã³ãã¹ããâïŒãâïŒâã¡ããã·
âã¹ããâãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãž
ã³ãâ2â²ïŒ5â²âãžãªã³ ã»ã·ã¯ããã³ã¿ã³ãã¹ããâïŒãâïŒâã¡ãã«â
ã¹ããâãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ã
â2â²ïŒ5â²âãžãªã³ æ¬çºæã«ãã€ãŠæäŸãããååç©ã¯ãäžè¿°ã®åŠ
ãé£æ²»æ§çŸæ£ã§ããç³å°¿ç ã«ãšããªãçš®ã ã®æ ¢æ§
çç¶ãå䜵çç¶ãããšãã°ç³å°¿ç æ§çœå éïŒç³å°¿
ç æ§ç¥çµé害ïŒç³å°¿ç ã«èµ·å ããçš®ã ã®åè硬å
æ§è¡ç®¡é害ïŒããã³ç³å°¿ç æ§è çãç³å°¿ç æ§ç¶²è
çãªã©ã®çŽ°å°è¡ç®¡é害ãªã©ã®æ²»çã»äºé²ã«æçšã§
ããã®ã§ãæ¬çºæã¯æ¥µããŠäŸ¡å€ã®é«ããã®ã§ãã
ãã以äžã«ãã®å¹æãæŽã«è©³çŽ°ã«èª¬æããã æ¬çºæã«ããååç©ã¯ãäžèšã«ç€ºãå®éšäŸïŒã«
ãã€ãŠæãããªåŠããç³å°¿ç ã©ããã®æ°Žæ¶äœãã
ã³å骚ç¥çµã®ãœã«ãããŒã«èç©ãããªãé«åºŠã«äœ
äžãé»å®³ãããå¯Ÿç §ååç©ãšããŠç¹èš±åºé¡å ¬éæ
å53幎第53653å·ã«èšèŒãããŠãã代衚ååç©ïŒ
âãã«ãªãâã¹ããâãã¯ããã³âïŒïŒ4â²âã€ã
ããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³ãéžæããããäž
èšã®å®éšäŸã«ç€ºãåŠããæ¬çºæååç©ã¯ãå¯Ÿç §å
åç©ãšæ¯èŒããŠãœã«ãããŒã«èç©æå¶çã«ãããŠ
極ããŠåªããŠãããç¹ã«äžèšã®è¡šïŒã«ç€ºãåŠãã
æ¬çºæååç©ã§ããïŒâãã«ãªãâïŒâã¡ãã«â
ã¹ããâãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³â
2â²ïŒ5â²âãžãªã³ããã³ïŒâã¯ããâïŒâã¡ãã«â
ã¹ããâãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³â
2â²ïŒ5â²âãžãªã³ã¯ãå¯Ÿç §ååç©ãšæ¯èŒããŠããœã«
ãããŒã«èç©æå¶çã«ãããŠçŽïŒã10åã®åªãã
å¹æã瀺ããæŽã«è©³ããè¿°ã¹ãã°æ¬çºæååç©ã¯
ç¹ã«å骚ç¥çµã«ããããœã«ãããŒã«èç©æå¶çã«
ãããŠæ¥µããŠåªããŠããã®ã§ãç¥çµç³»ã«ãã匷ã
äœçšããããšãèããããããã®ããšã¯ãç³å°¿ç
å䜵çäžã®é£ç ã®äžã€ã§ããæ«æ¢¢ç¥çµçïŒããŠãŒ
ããããŒïŒãªã©ã«ç¹ã«æå©ã§ããã äžè¿°ã®åŠããœã«ãããŒã«èç©æå¶ã«ãããŠæ¥µã
ãŠåªããå¹æã瀺ãããšã¯ãæ¬çºæã®åŠãç³å°¿ç
æ§çœå éãç³å°¿ç æ§ç¥çµé害ãªã©ã®ç³å°¿ç æ§å䜵
çã®ãããªæ ¢æ§çé£ç ã«ãããŠã¯ãé£ç¶æäžãäœ
åãªããããã®ã§ã極ããŠå°éã®æäžéã§å¹æã
瀺ãããšãæå³ããŠãããéåžžã«éèŠãªããšã§ã
ãã ãã®ããšã¯ã¬ã©ã¯ããŒã¹çœå éã©ããã«ããã
åŸè¿°ã®å®éšäŸïŒã«ãããŠãå šãåæ§ã§ãããããª
ãã¡ãæ¬çºæååç©ã¯ãã¬ã©ã¯ããŒã¹è¡çã©ãã
ã®çœå éã®åœ¢æãèããé 延ãããæ°Žæ¶äœããã³
å骚ç¥çµäžã®ã¬ã©ã¯ãããŒã«èç©ãããªãé«åºŠã«
äœäžãé»å®³ããããããŠãå®éšäŸïŒã§æãããªåŠ
ããæ¬çºæååç©ã¯å¯Ÿç §ååç©ãšæ¯èŒããŠãçœå
éã®åºçŸçã極ããŠäœãããŸãã¬ã©ã¯ãããŒã«è
ç©æå¶çã«ãããŠïŒå以äžããããŠããã ãŸãåŸè¿°ã®å®éšäŸïŒã«ãããŠæãããªåŠããæ¬
çºæååç©ã¯ãã¢ã«ããŒã¹ ãªãã¯ã¿ãŒãŒé»å®³äœ
çšã«ãããŠã極ããŠåªããŠããã æŽã«ãæ¬çºæã«ãã€ãŠæäŸãããååç©ã¯ãäž
æ¢äœçšã®äžã€ã®ææšã§ããæã¡ãã©ãŸãŒã«äœçšã
å¯Ÿç §ååç©ãšæ¯èŒããŠåŒ±ãããšãå€æããŠããã
çµå±ãããäžæ¢äœçšã匱ããããå¯äœçšãå°ãªã
èšåºçã¡ãªããã¯æ¥µããŠå€§ããã äžè¿°ããåŠãçŸæ£ã®æ§è³ªããé·æé£çšæäžãå¿
èŠãšãããã®ã§ãæ¬çºæååç©ã¯ãã®ç¹ããã䟡
å€ã®é«ããã®ã§ããã 次ã«æ¬çºæååç©ã®åªããè¬çäœçšãæ¬çºæã®
代衚çååç©ã«ã€ããŠä»¥äžã«å®éšäŸã«ãŠå ·äœçã«
説æããã å®éšäŸ ïŒ ã¹ãã¬ãããŸãã·ã³èªçºç³å°¿ç ã©ããã®æ°Žæ¶äœ
ããã³å骚ç¥çµãžã®ãœã«ãããŒã«ã®èç©ãäœäžãŸ
ãã¯é»å®³ãã掻æ§ã®æž¬å® ã¹ãã¬ãããŸãã·ã³èªçºç³å°¿ç ã©ããã®æ°Žæ¶äœ
ããã³å骚ç¥çµã®ãœã«ãããŒã«ã®èç©ã®äœäžãŸã
ã¯é»å®³ããèœåãè¡šïŒããã³è¡šïŒã«ç€ºãååç©ã«
ã€ããŠM.J.Peterson et alïŒMetabolismïŒVol
28ïŒNo.ïŒïŒSuppl.1ïŒAprilïŒïŒ1979ïŒ456ã461ã«èš
èŒã®æ¹æ³ã«ããè©Šéšãããå¯Ÿç §ååç©ãšããŠã¯ã
åè¿°ããç¹èš±åºé¡å ¬éæå53幎第53653å·ã«èšèŒ
ãããŠãã代衚çååç©ïŒâãã«ãªãâã¹ãã
ãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²â
ãžãªã³ãéžæãããå®éšã¯ãã©ããã®æ°Žæ¶äœãã
ã³å骚ç¥çµäžã®ãœã«ãããŒã«èç©éããç³å°¿ç èª
çºåŸ28æéã«ããã枬å®ããããšã«ãããããªã
ãããããªãã¡ãã¹ãã¬ãããŸãã·ã³æäžåŸã
ïŒïŒïŒïŒ25æéåŸã«ãè¡šïŒããã³è¡šïŒã«ç€ºãåå
ç©ãããããã®æäžéã«ãŠæäžãããããªãã¡è¡š
ïŒã®å®éšã¯0.2mgïŒKgãïŒmgïŒKgããã³ïŒmgïŒKg
ã®æäžéã§ã®å®éšã§ãè¡šïŒã¯10mgïŒKgã®æäžéã§
ã®å®éšã§ãããçµæãè¡šïŒããã³è¡šïŒã«ç€ºããè¡š
ïŒããã³è¡šïŒã«ãããæå¶çãšã¯ãã³ã³ãããŒã«
ãšæ¯èŒããŠè©Šéšååç©ã«ãã€ãŠéæãããé»å®³ïŒ
ã瀺ãã ãªãè¡šïŒããã³è¡šïŒã«ãããååç©ã«ãããŠã
ïŒâãã«ãªãâïŒâã¡ãã«âã¹ããâãã¯ããã³
âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³ãã
ã³ïŒâã¯ããâïŒâã¡ãã«âã¹ããâãã¯ããã³
âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³ã¯ã
åŸè¿°ã®åæäŸïŒããã³åæäŸïŒã«ãããŠåªå¢ã«ç
æããååç©ãããªãã¡ãããããèç¹233ã235
âãèç¹283ã285âãæããçµæ¶ãæå³ããã
çšè¬å€ã«é¢ãããæŽã«è©³ããè¿°ã¹ãã°ã äžè¬åŒ ïŒåŒäžX1ããã³X2ã¯åäžãŸãã¯ç°ãªã€ãŠãã
ããæ°ŽçŽ ååãããã²ã³ååãäœçŽã¢ã«ãã«åºã
ãŸãã¯äœçŽã¢ã«ã³ãã·åºãæå³ããã¯é žçŽ åå
ãŸãã¯ç¡«é»ååãæå³ããR1ããã³R2ã¯åäžãŸ
ãã¯ç°ãªã€ãŠããããæ°ŽçŽ ååãäœçŽã¢ã«ãã«
åºãããšãã«åºããŸãã¯äž¡è ãšãããã«çµåããŠ
ããççŽ ååãšã§ç°ã圢æãããäœããR1ãã
ã³R2ãåæã«æ°ŽçŽ ååã§ããå Žåã¯é€ããïœã¯
ïŒãŸãã¯ïŒã®æŽæ°ãæå³ãããïŒã§è¡šããããã
ãã³ãã€ã³èªå°äœããã³ãã®å¡©ãæå¹æåãšãã
ç³å°¿ç ã«ãšããªãæ ¢æ§çç¶ã»å䜵çç¶ã®æ²»çã»äº
é²å€ã«é¢ãããã®ã§ããã äžèšäžè¬åŒããã«ãããŠãX1ïŒX2ïŒR1ïŒã
ãã³R2ã®å®çŸ©äžã«ã¿ãããäœçŽã¢ã«ãã«åºãŸã
ã¯äœçŽã¢ã«ã³ãã·åºãšã¯ççŽ æ°ïŒãïŒã®çŽéè¥ã
ãã¯åæç¶ã®ã¢ã«ãã«åºãäŸãã°ã¡ãã«ããšã
ã«ãïœâãããã«ãã€ãœãããã«ãïœâããã«ã
ã€ãœããã«ãtertâããã«ãïœâãã³ãã«ãã€ãœ
ã¢ãã«ãïœâããã·ã«åºãªã©ã®ã¢ã«ãã«åºè¥ãã
ã¯ãããã«åºã¥ãã¢ã«ã³ãã·åºãæå³ããããŸã
X1ããã³X2ã®å®çŸ©äžã«ã¿ãããããã²ã³ååãš
ã¯å ·äœçã«ã¯å¡©çŽ ãèçŽ ããšãŠçŽ ãããçŽ ãæå³
ããããŸããR1ããã³R2ã®å®çŸ©äžã«ã¿ãããäž¡
è ãšãããã«çµåããŠããççŽ ååãšã§ç°ã圢æ
ããå Žåã®äŸãå ·äœçã«è¿°ã¹ãã°ãã·ã¯ããã
ã«ãã·ã¯ããã³ãã«ãã·ã¯ãããã·ã«åºãªã©ãæ
å³ããã æ¬çºæã«ãããŠãã®å¡©ãšã¯ãå»è¬ãšããŠèš±å®¹ã§
ããå¡©ãæå³ããå ·äœçã«ã¯ããããªãŠã ãã«ãª
ãŠã ãã«ã«ã·ãŠã ããã°ãã·ãŠã ãªã©ã®éœã€ãªã³
ãšã®å¡©ãæå³ããã ãŸãæ¬çºæååç©ã¯ããã®æ§é äžïŒãªããïŒå
ã®äžæççŽ ååãæããããïŒåã®ç«äœç°æ§äœã
ããã³ããããã®å åŠç°æ§äœãååšãããããæ¬
çºæã«ãããŠã¯ãããã®ãããããå«ãããšã¯ã
ããŸã§ããªãã æ¬çºæã«ãã€ãŠæäŸãããããã³ãã€ã³èªå°äœ
ã¯ãç³å°¿ç ã«äŒŽãçš®ã ã®æ ¢æ§çç¶ãããªãã¡ãç³
å°¿ç ã®å䜵çããšãã°ç³å°¿ç æ§çœå éãç³å°¿ç æ§
ç¥çµé害ãç³å°¿ç æ§è çãªã©ã®çŽ°å°è¡ç®¡é害ãç³
å°¿ç æ§ç¶²èçãããã³ç³å°¿ç ã«èµ·å ããçš®ã ã®å
è硬åæ§è¡ç®¡é害ïŒå 倩æ§ã¬ã©ã¯ããŒã¹è¡çã«äŒŽ
ãªãçœå éãªã©ã®æ²»çããã³äºé²ã«åªããå¹æã
æããã æ¬çºæã«ãããŠãç³å°¿ç ã«ãšããªãæ ¢æ§çç¶ã»
å䜵çç¶ãšã¯ãäŸãã°ç³å°¿ç æ§çœå éïŒç³å°¿ç æ§
ç¥çµé害ïŒç³å°¿ç æ§è çãŸãã¯ç³å°¿ç æ§ç¶²èçãª
ã©ã®çŽ°å°è¡ç®¡é害ïŒããã³ç³å°¿ç ã«èµ·å ããçš®ã
ã®åè硬åæ§è¡ç®¡é害ïŒå 倩æ§ã¬ã©ã¯ããŒã¹è¡ç
ã«äŒŽãªãçœå éãªã©ãæå³ããããç³å°¿ç ã«èµ·å
ããçŸæ£ã§ããã°ãããããå å«ãããã®ã§ã
ãã åŸæ¥ãã¹ã«ããã«ãŠã¬ã¢å€ãã¡ãŸèé žå¡©å€ãã°
ã¢ããžã³èªå°äœãªã©å€æ°ã®ç³å°¿ç æ²»çè¬ãåžå Žã«
ã ãããŠãããããããã¯éè¡ç³ã«å¯Ÿãã察çç
ãªæ²»çè¬ã§ã決å®çãªç³å°¿ç æ²»çè¬ã¯ãªãã æ®ã«ãç³å°¿ç ã«ãšããªãçš®ã ã®æ ¢æ§çç¶ãå䜵
çç¶ãããšãã°ç³å°¿ç æ§çœå éãç³å°¿ç æ§ç¥çµé
害ãç³å°¿ç æ§ç¶²èçãªã©ã®æ²»çå€ã¯ãã»ãšãã©ãª
ããæå¹ãªæ²»çæ³ã¯å šããªããšãã€ãŠãéèšã§ã¯
ãªãã®ãå®æ ã§ãããæ®ã«æ°Žæ¶äœã®æ··æ¿ã§ããçœ
å éã«ã€ããŠã¯è¬å€ã«ããæå¹ãªæ²»çæ³ã¯ã»ãšã
ã©ãªãã äžèšã®ãããªå®æ ããããã®ãããªé£æ²»æ§çŸæ£
ã«æå¹ãªæ²»çè¬ã®ç 究ãé·å¹Žã«ããã€ãŠãããªã
ããŠããããæªã æåããäŸã¯ã»ãšãã©ãªãã ãã®ç 究ã®äžæ¹åãšããŠã¯ã¢ã«ããŒã¹ ãªãã¯
ã¿ãŒãŒïŒAldose reductaseïŒé»å®³ç©è³ªã®æ¢çŽ¢ã§
ãããããªãã¡ã1973幎J.H.Kinoshitaã
ïŒScienseïŒ182ïŒ1146âïŒïŒ1973ïŒã¯ãç³å°¿ç æ§
çœå éæ£è ã«ãããŠãçŒæ°Žæ¶äœäžã®ã¢ã«ããŒã¹
ãªãã¯ã¿ãŒãŒã®æŽ»æ§ãé«ãŸããæµå ¥ããã°ã«ã³ãŒ
ã¹ãã¬ã©ã¯ããŒã¹ãªã©ã®ç³ããã®é µçŽ ã«ããéå
ãããŠãœã«ãããŒã«ãã¬ã©ã¯ãããŒã«ãªã©ã®ããª
ãªãŒã«ãšãªãããããã®ããªãªãŒã«ã®èç©ãæ°Žæ¶
äœãªã©ã®åºè³ªé害ãèµ·ãäž»ããåå ã§ãããšã®èª¬
ãçºè¡šããããã以æ¥ãã®J.H.Kinoshitaã®çè«
ã«åºã¥ãã¢ã«ããŒã¹ ãªãã¯ã¿ãŒãŒé»å®³ç©è³ªã®æ¢
玢ãåºããããªãããŠããã ããããŠãã¬ã€ã³ããŒãã»ãµãŒãžãšã¹ã¯ç¹å®ã®
ããã³ãã€ã³èªå°äœã«ã¢ã«ããŒã¹ ãªãã¯ã¿ãŒãŒ
é»å®³äœçšãããããšãèŠãåºãïŒç¹èš±å ¬éæå53
幎第53653å·ãªã©ïŒããããã®äžã§ç¹ã«ïœâïŒâã
ã«ãªããŒã¹ãããŒãã¯ããã³âïŒïŒ4â²âã€ãããŸ
ãªãžã³ãâ2â²ïŒ5â²âãžãªã³ïŒäžè¬åãœã«ããã«ïŒ
ãææ¡ãããŠããã æ¬çºæè çããäžè¿°ã®åŠãåŸæ¥å€§å€å°é£ãšãã
ãŠãããã®çš®ã®é£æ²»æ§çŸæ£ãããªãã¡ç³å°¿ç ã«ãš
ããªãçš®ã ã®æ ¢æ§çç¶ãå䜵çç¶ã®æ²»çè¬ã®ç
究ã»éçºãç®çãšããŠãé·å¹Žãšããã¿åçš®ã®ç¡æ°
ã®ååç©ã®æ¢çŽ¢ãããæå¹ãªååç©ã®çºèŠã¯æ¥µã
ãŠå°é£æ§ããããããããããã次ã®äžè¬åŒ ïŒåŒäžX1ããã³X2ã¯åäžãŸãã¯ç°ãªã€ãŠãã
ããæ°ŽçŽ ååãããã²ã³ååãäœçŽã¢ã«ãã«åºã
ãŸãã¯äœçŽã¢ã«ã³ãã·åºãæå³ããã¯é žçŽ åå
ãŸãã¯ç¡«é»ååãæå³ããR1ããã³R2ã¯åäžãŸ
ãã¯ç°ãªã€ãŠããããæ°ŽçŽ ååãäœçŽã¢ã«ãã«
åºãããšãã«åºããŸãã¯äž¡è ãšãããã«çµåããŠ
ããççŽ ååãšã§ç°ã圢æãããäœããR1ãã
ã³R2ãåæã«æ°ŽçŽ ååã§ããå Žåã¯é€ããïœã¯
ïŒãŸãã¯ïŒã®æŽæ°ãæå³ãããïŒã§è¡šããããã
ãã³ãã€ã³èªå°äœãããã®é£æ²»æ§çŸæ£ã«æ¥µããŠæ
å¹ã§ããããšãèŠãåºããæ¬çºæãå®æãããã®
ã§ããã æ¬çºæã«ãã€ãŠæäŸãããååç©çŸ€ã¯ã¢ã«ããŒ
ã¹ ãªãã¯ã¿ãŒãŒé»å®³æŽ»æ§ã極ããŠåŒ·ãã®ã¿ãªã
ããç¹èšãã¹ãããšã¯çäœïŒin vivoïŒã«ãããŠã
é©ãã¹ã匷åãªäœçšãçºæ®ããããšã§ãããæŽã«
æ¬çºæã«ãã€ãŠæäŸãããååç©çŸ€ã¯ãæ¯æ§ã極
ããŠåŒ±ããäžæ¢äœçšçä»ã®äœçšã極ããŠåŒ±ããã
ã®ããšã¯èšåºçã«æäžéã極ããŠå°ãªããŠããã
ãšãæå³ããŠãããæ¬çºæã®é©å¿çã§ããç³å°¿ç
æ§çœå éïŒç³å°¿ç æ§ç¥çµé害ïŒç³å°¿ç æ§ç¶²èçã
ç³å°¿ç æ§è çãªã©ã®çŽ°å°è¡ç®¡é害ïŒããã³ç³å°¿ç
ã«èµ·å ããçš®ã ã®åè硬åæ§è¡ç®¡é害ãªã©ã®ã€ã³
ã¹ãªã³éäŸåæ§çµç¹é害ã«åºã¥ãç³å°¿ç æ ¢æ§ç
ç¶ã»å䜵çç¶ã«ãããŠã¯å¿ ç¶çã«é£ç¶æäžãäœå
ãªããããããšãèæ ®ãããšæ¥µããŠéèŠãªããšã§
ããã ãŸããäžè¿°ã®åŠããã®çš®ã®é£æ²»æ§çŸæ£ã«çŸåšæ²»
çè¬ãã»ãšãã©ãªãããšãããæ¬çºæã«ããåå
ç©ã¯æ¥µããŠäŸ¡å€ã®é«ããã®ã§ããã ãã€ãŠãæ¬çºæã®ç®çã¯ãç³å°¿ç ã«ãšããªãã€
ã³ã¹ãªã³éäŸåæ§çµç¹é害ã«åºã¥ãçš®ã ã®æ ¢æ§ç
ç¶ãå䜵çç¶ãããšãã°ç³å°¿ç æ§çœå éïŒç³å°¿ç
æ§ç¥çµé害ïŒç³å°¿ç æ§ç¶²èçãç³å°¿ç æ§è çãªã©
ã®çŽ°å°è¡ç®¡é害ããã³ç³å°¿ç ã«èµ·å ããçš®ã ã®å
è硬åæ§è¡ç®¡é害ãªã©ã«æå¹ãªæ°èŠè¬å€ãæäŸã
ãã«ããã æ¬çºæååç©ã¯ãçš®ã ã®æ¹æ³ã«ãã€ãŠè£œé ãã
ããããã®ä»£è¡šçãªæ¹æ³ã瀺ãã°æ¬¡ã®ãšããã§ã
ãã ïŒåŒäžX1ïŒX2ïŒR1ïŒR2ïŒïŒ¹ããã³ïœã¯åèšã®
æå³ãæãããïŒ ããªãã¡ãæ¬çºæã®ååç©ã¯ã(1)äžèšã®ãã
åŒã§ç€ºãããååç©ãšã(2)ã·ã¢ã³åãããªãŠã ã
ã·ã¢ã³åã«ãªãŠã ã®åŠãã¢ã«ã«ãªéå±ã·ã¢ã³å
ç©ãããã³(3)çé žã¢ã³ã¢ããŠã ã®äžè ãçž®åãã
ãããšã«ãã補é ãããã æ¬åå¿ã®éçšãã奜ãŸãã溶åªã®äŸãããã
ã°ãã¢ã»ãã«ã¢ããã®åŠãäœçŽã¢ã«ã«ãã¢ããã
ã¡ã¿ããŒã«ããšã¿ããŒã«ããããããŒã«ã®åŠãæ°Ž
ãšæ··åããã¢ã«ã«ããŒã«ããžãªããµã³ããã³ãã
ã©ããããã©ã³ã®åŠãç°ç¶ãšãŒãã«ããšãã¬ã³ã°
ãªã³ãŒã«ãããªã¡ãã¬ã³ã°ãªã³ãŒã«ã®åŠãäœçŽã¢
ã«ãã¬ã³ã°ãªã³ãŒã«ãïŒïŒ®âãžã¡ãã«ãã«ã ã¢
ãããïŒïŒ®âãžãšãã«ãã«ã ã¢ããã®åŠãïŒ
âãžã¢ã«ãã«ã¢ãããªã©ããããããšãã§ã
ãã åå¿ã¯äžèšããåŒã§ç€ºãããåºçºç©è³ªã®éã
ã«ãã€ãŠå·Šå³ããããã奜ãŸãã枩床ãšããŠã¯é
åžž50ã150âã®æž©åºŠã§çŽïŒæéãçŽïŒæ¥éãããª
ãããã åå¿ã«éããäžè¿°ã®åºçºç©è³ª(1)ã(2)ã(3)ã®éç
é¢ä¿ã«ã€ããŠã¯ã奜ãŸããã¯éåžž(1)ã®ååç©ã«å¯Ÿ
ããå°ãªããšããããã«éå°ã®(2)ã®ã¢ã«ã«ãªéå±
ã·ã¢ã³åç©ãããã³(3)ã®çé žã¢ã³ã¢ããŠã ãçšã
ããæ¬çºæã®ç®çç©è³ªããã¯ãåå¿å®çµåŸãé
åžžã®æ¹æ³äŸãã°ãŸãæ°Žã§åå¿æ··åç©ãåžéãã次
ãã§åŸããã氎溶液ã宀枩ã«å·åŽããåŸãé žæ§ã«
ããããšã«ããç®çç©è³ªããã容æã«ååã§ã
ãæ²æ®¿ç©ã®åœ¢ã§åé¢ãããã ç®çç©è³ªããã«ãããŠãR1ããã³R2ã®ãã
ãããæ°ŽçŽ ã§ããïŒâã¢ã眮æèªå°äœã®å Žåã«äž
æççŽ ïŒåã®ååšã«åºã¥ãïŒçš®ã®ç«äœç°æ§äœã®ç
æãäºæ³ãããããæ¬è£œé æ¹æ³ã«ããã°ãäžæ¹ã®
ç°æ§äœãç«äœç¹ç°çåªå¢ãã§è£œé ããããããã
ã®ç°æ§äœãåŸè¿°ãããœã«ãããŒã«èç©æå¶çãªã©
掻æ§ãé«ãã®ã§ããããŠå¥œãŸããæ¹æ³ãšãããã ãã®è£œé æ¹æ³ã«ãããŠåºçºç©è³ªã§ããäžè¬åŒ
ããã®ååç©ã¯çš®ã ã®æ¹æ³ã§è£œé ã§ãããæ¬çº
æã«ãããŠã¯ãããªã補é æ¹æ³ã§è£œé ããããã®
ã§ã䜿çšã§ããããšã¯ãããŸã§ããªãã äŸãã°äžèšã®äžè¬åŒããã«ãããŠãX1ïŒïŒšïŒ
X2ïŒïŒâïŒR1ïŒïŒšïŒR2ïŒCH3ïŒïœïŒïŒïŒïŒ¹ïŒ
ïŒã§ããïŒâãã«ãªãâïŒâã¡ãã«âïŒâã¯ãã
ãã³ã¯ãâãã«ãªãããšããŒã«ãšã¯ããã³é žã
ããªãªã³é žã®ååšäžã§çž®åéç°ãããããšã«ãã
åŸãããããŸãäžè¬åŒããã«ãããŠãX1ïŒïŒšïŒ
X2ïŒïŒâClïŒïœïŒïŒïŒïŒ¹ïŒïŒïŒR1ããã³R2ãã·
ã¯ããããµã³ç°ã圢æããå Žåã§ããïŒâã¯ãã
âïŒâã¹ããâã·ã¯ããããµã³âïŒâã¯ãããã³
ã¯ãïŒâãã€ãããã·âïŒâã¯ããã¢ã»ãããšã
ã³ãšã·ã¯ããããµãã³ãããããªãžã³ãªã©ã®ååš
äžã§çž®åéç°ããããšã«ããåŸãããã ãŸãäžè¬åŒããã«ãããŠãX1ïŒïŒšïŒX2ïŒïŒ
âClïŒïœïŒïŒïŒïŒ¹ïŒïŒïŒR1ïŒR2ïŒCH3ã§ããå Ž
åã§ããïŒâã¯ããâïŒïŒïŒâãžã¡ãã«âïŒâã
ã³ãŸãã©ãã³ã¯ãäŸãã°æ¬¡ã®åå¿åŒã«ããåæã
ããã ãŸãäžè¬åŒããã«ãããŠãX1ïŒïŒšïŒX2ïŒïŒ
âClïŒïœïŒïŒïŒïŒ¹ïŒïŒïŒR1ïŒïŒšïŒR2ïŒCH3ã§ã
ãå Žåã§ããïŒâã¯ããâïŒâã¡ãã«âïŒâãã³
ãŸãã©ãã³ã¯ãäžèšã®ïŒâã¯ããâïŒïŒïŒâãžã¡
ãã«âïŒâãã³ãŸãã©ãã³ã«æºããæ¹æ³ã«ããã
äŸãã°æ¬¡ã®åå¿åŒã«ããåæããã ãŸãäžè¬åŒããã«ãããŠãX1ïŒïŒšïŒX2ïŒïŒ
âClïŒïœïŒïŒïŒïŒ¹ïŒïŒ³ïŒR1ïŒïŒšïŒR2ïŒCH3ã§ã
ãïŒâã¯ããâïŒâã¡ãã«âïŒâããªã¯ãããã³
ã¯ãâã¯ããããªããšããŒã«ãšã¯ããã³é žãã
ãªãªã³é žã®ååšäžã§çž®åéç°ãããããšã«ããåŸ
ãããã æŽã«äžè¬åŒããã«ãããŠX1ïŒïŒšïŒX2ïŒïŒâ
ClïŒïœïŒïŒïŒïŒ¹ïŒïŒïŒR1ïŒïŒšïŒR2ïŒããšãã«åº
ã§ããïŒâã¯ããâïŒâããšãã«âïŒâã¯ããã
ã³ã¯äŸãã°æ¬¡ã®åå¿åŒã«ããåæããã æ¬çºæã®ä»£è¡šçãªååç©ãšããŠã¯äŸãã°ä»¥äžã®
ååç©ããããããã ã»ïŒâãã«ãªãâïŒâã¡ãã«âã¹ããâãã¯ãã
ã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³ ã»ïŒâã¯ããâïŒâã¡ãã«âã¹ããâãã¯ããã³
âïŒïŒ4â²âã€ãããŸãªãžã³ã2â²ïŒ5â²âãžãªã³ ã»ïŒâã¯ããâïŒïŒïŒâãžã¡ãã«âã¹ããâãã¯
ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãž
ãªã³ ã»ïŒâãã«ãªãâïŒïŒïŒâãžã¡ãã«âã¹ããâ
ãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ
5â²âãžãªã³ ã»ïŒâã¯ããâïŒïŒïŒâãžã¡ãã«âã¹ããâãã
ã³ãŸãã©ã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ
5â²âãžãªã³ ã»ïŒâãã«ãªãâïŒïŒïŒâãžã¡ãã«âã¹ããâ
ããã³ãŸãã©ã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ
2â²ïŒ5â²âãžãªã³ ã»ïŒâã¯ããâïŒâã¡ãã«âã¹ããâããã³ãŸã
ã©ã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãª
ã³ ã»ïŒâãã«ãªãâïŒâã¡ãã«âã¹ããâããã³ãŸ
ãã©ã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãž
ãªã³ ã»ïŒâã¡ãã«âïŒïŒïŒâãžã¡ãã«âã¹ããâãã¯
ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãž
ãªã³ ã»ïŒâã¡ããã·âïŒïŒïŒâãžã¡ãã«âã¹ããâ
ãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ
5â²âãžãªã³ ã»ïŒïŒïŒâãžã¯ããâïŒïŒïŒâãžã¡ãã«âã¹ãã
âãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ
5â²âãžãªã³ ã»ïŒâããã¢âïŒïŒïŒâãžã¡ãã«âã¹ããâãã¯
ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãž
ãªã³ ã»ïŒâãã«ãªãâïŒïŒïŒâãžãšãã«âã¹ããâ
ãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ
5â²âãžãªã³ ã»ïŒâã¯ããâïŒâãšãã«âã¹ããâãã¯ããã³
âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³ ã»ïŒâã¯ããâïŒâïœâãããã«âã¹ããâãã¯
ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãž
ãªã³ ã»ïŒâãã«ãªãâïŒâãšãã«âã¹ããâãã¯ãã
ã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³ ã»ïŒâãã«ãªãâïŒâïœâãããã«âã¹ããâ
ãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ
5â²âãžãªã³ ã»ïŒâã¯ããâïŒâã€ãœããã«âã¹ããâãã¯ã
ãã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãª
ã³ ã»ïŒâã¯ããâïŒâã€ãœãããã«âã¹ããâãã¯
ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãž
ãªã³ ã»ïŒâã¯ããâïŒâïœâããã«âã¹ããâãã¯ã
ãã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãª
ã³ ã»ïŒâã¡ããã·âïŒâã¡ãã«âã¹ããâãã¯ãã
ã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³ ã»ïŒâã¯ããâïŒâã¡ãã«âã¹ããâãã¯ããã³
âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³ ã»ïŒâã¡ãã«âïŒâã¡ãã«âã¹ããâãã¯ããã³
âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³ ã»ïŒïŒïŒâãžã¯ããâïŒâã¡ãã«âã¹ããâãã¯
ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãž
ãªã³ ã»ïŒïŒïŒâãžã¡ãã«âã¹ããâãã¯ããã³âïŒïŒ
4â²âã€ãããŸãªãžã³ã2â²ïŒ5â²âãžãªã³ ã»ïŒâã¡ãã«âã¹ããâãã¯ããã³âïŒïŒ4â²âã€
ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³ ã»ïŒïŒïŒâãžã¡ãã«âã¹ããâãããªã¯ããã³â
ïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³ ã»ïŒâã¯ããâïŒâããšãã«âã¹ããâãã¯ãã
ã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³ ã»ïŒâãã«ãªãâïŒâã¡ãã«âã¹ããâãããªã¯
ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãž
ãªã³ ã»ïŒâãã«ãªãâïŒïŒïŒâãžã¡ãã«âã¹ããâ
ãããªã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ
2â²ïŒ5â²ãžãªã³ ã»ïŒâã¯ããâïŒâã¡ãã«âã¹ããâãããªã¯ã
ãã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãª
ã³ ã»ïŒâã¯ããâïŒïŒïŒâãžãšãã«âã¹ããâãã
ãªã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ
5â²âãžãªã³ ã»ïŒâãã«ãªãâïŒïŒïŒâãžã¡ãã«âã¹ããâ
ãããªã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ
2â²ïŒ5â²âãžãªã³ ã»ïŒïŒïŒâãžã¯ããâïŒïŒïŒâãžã¡ãã«âã¹ãã
âãããªã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ
2â²ïŒ5â²âãžãªã³ ã»ïŒâãã«ãªãâïŒâïœâãã³ãã«âã¹ããâ
ãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ
5â²âãžãªã³ ã»ïŒâã¯ããâïŒâïœâããã·ã«âã¹ããâãã¯
ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãž
ãªã³ ã»ã·ã¯ããããµã³ãã¹ããâïŒãâïŒâã¡ãã«â
ã¹ããâãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ã
â2â²ïŒ5â²âãžãªã³ ã»ã·ã¯ããããµã³ãã¹ããâïŒãâïŒâã¯ããâ
ã¹ããâãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ã
â2â²ïŒ5â²âãžãªã³ ã»ã·ã¯ããã³ã¿ã³ãã¹ããâïŒãâïŒâã¯ããâ
ã¹ããâãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ã
â2â²ïŒ5â²âãžãªã³ ã»ã·ã¯ããã³ã¿ã³ãã¹ããâïŒãâïŒâã¡ããã·
âã¹ããâãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãž
ã³ãâ2â²ïŒ5â²âãžãªã³ ã»ã·ã¯ããã³ã¿ã³ãã¹ããâïŒãâïŒâã¡ãã«â
ã¹ããâãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ã
â2â²ïŒ5â²âãžãªã³ æ¬çºæã«ãã€ãŠæäŸãããååç©ã¯ãäžè¿°ã®åŠ
ãé£æ²»æ§çŸæ£ã§ããç³å°¿ç ã«ãšããªãçš®ã ã®æ ¢æ§
çç¶ãå䜵çç¶ãããšãã°ç³å°¿ç æ§çœå éïŒç³å°¿
ç æ§ç¥çµé害ïŒç³å°¿ç ã«èµ·å ããçš®ã ã®åè硬å
æ§è¡ç®¡é害ïŒããã³ç³å°¿ç æ§è çãç³å°¿ç æ§ç¶²è
çãªã©ã®çŽ°å°è¡ç®¡é害ãªã©ã®æ²»çã»äºé²ã«æçšã§
ããã®ã§ãæ¬çºæã¯æ¥µããŠäŸ¡å€ã®é«ããã®ã§ãã
ãã以äžã«ãã®å¹æãæŽã«è©³çŽ°ã«èª¬æããã æ¬çºæã«ããååç©ã¯ãäžèšã«ç€ºãå®éšäŸïŒã«
ãã€ãŠæãããªåŠããç³å°¿ç ã©ããã®æ°Žæ¶äœãã
ã³å骚ç¥çµã®ãœã«ãããŒã«èç©ãããªãé«åºŠã«äœ
äžãé»å®³ãããå¯Ÿç §ååç©ãšããŠç¹èš±åºé¡å ¬éæ
å53幎第53653å·ã«èšèŒãããŠãã代衚ååç©ïŒ
âãã«ãªãâã¹ããâãã¯ããã³âïŒïŒ4â²âã€ã
ããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³ãéžæããããäž
èšã®å®éšäŸã«ç€ºãåŠããæ¬çºæååç©ã¯ãå¯Ÿç §å
åç©ãšæ¯èŒããŠãœã«ãããŒã«èç©æå¶çã«ãããŠ
極ããŠåªããŠãããç¹ã«äžèšã®è¡šïŒã«ç€ºãåŠãã
æ¬çºæååç©ã§ããïŒâãã«ãªãâïŒâã¡ãã«â
ã¹ããâãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³â
2â²ïŒ5â²âãžãªã³ããã³ïŒâã¯ããâïŒâã¡ãã«â
ã¹ããâãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³â
2â²ïŒ5â²âãžãªã³ã¯ãå¯Ÿç §ååç©ãšæ¯èŒããŠããœã«
ãããŒã«èç©æå¶çã«ãããŠçŽïŒã10åã®åªãã
å¹æã瀺ããæŽã«è©³ããè¿°ã¹ãã°æ¬çºæååç©ã¯
ç¹ã«å骚ç¥çµã«ããããœã«ãããŒã«èç©æå¶çã«
ãããŠæ¥µããŠåªããŠããã®ã§ãç¥çµç³»ã«ãã匷ã
äœçšããããšãèããããããã®ããšã¯ãç³å°¿ç
å䜵çäžã®é£ç ã®äžã€ã§ããæ«æ¢¢ç¥çµçïŒããŠãŒ
ããããŒïŒãªã©ã«ç¹ã«æå©ã§ããã äžè¿°ã®åŠããœã«ãããŒã«èç©æå¶ã«ãããŠæ¥µã
ãŠåªããå¹æã瀺ãããšã¯ãæ¬çºæã®åŠãç³å°¿ç
æ§çœå éãç³å°¿ç æ§ç¥çµé害ãªã©ã®ç³å°¿ç æ§å䜵
çã®ãããªæ ¢æ§çé£ç ã«ãããŠã¯ãé£ç¶æäžãäœ
åãªããããã®ã§ã極ããŠå°éã®æäžéã§å¹æã
瀺ãããšãæå³ããŠãããéåžžã«éèŠãªããšã§ã
ãã ãã®ããšã¯ã¬ã©ã¯ããŒã¹çœå éã©ããã«ããã
åŸè¿°ã®å®éšäŸïŒã«ãããŠãå šãåæ§ã§ãããããª
ãã¡ãæ¬çºæååç©ã¯ãã¬ã©ã¯ããŒã¹è¡çã©ãã
ã®çœå éã®åœ¢æãèããé 延ãããæ°Žæ¶äœããã³
å骚ç¥çµäžã®ã¬ã©ã¯ãããŒã«èç©ãããªãé«åºŠã«
äœäžãé»å®³ããããããŠãå®éšäŸïŒã§æãããªåŠ
ããæ¬çºæååç©ã¯å¯Ÿç §ååç©ãšæ¯èŒããŠãçœå
éã®åºçŸçã極ããŠäœãããŸãã¬ã©ã¯ãããŒã«è
ç©æå¶çã«ãããŠïŒå以äžããããŠããã ãŸãåŸè¿°ã®å®éšäŸïŒã«ãããŠæãããªåŠããæ¬
çºæååç©ã¯ãã¢ã«ããŒã¹ ãªãã¯ã¿ãŒãŒé»å®³äœ
çšã«ãããŠã極ããŠåªããŠããã æŽã«ãæ¬çºæã«ãã€ãŠæäŸãããååç©ã¯ãäž
æ¢äœçšã®äžã€ã®ææšã§ããæã¡ãã©ãŸãŒã«äœçšã
å¯Ÿç §ååç©ãšæ¯èŒããŠåŒ±ãããšãå€æããŠããã
çµå±ãããäžæ¢äœçšã匱ããããå¯äœçšãå°ãªã
èšåºçã¡ãªããã¯æ¥µããŠå€§ããã äžè¿°ããåŠãçŸæ£ã®æ§è³ªããé·æé£çšæäžãå¿
èŠãšãããã®ã§ãæ¬çºæååç©ã¯ãã®ç¹ããã䟡
å€ã®é«ããã®ã§ããã 次ã«æ¬çºæååç©ã®åªããè¬çäœçšãæ¬çºæã®
代衚çååç©ã«ã€ããŠä»¥äžã«å®éšäŸã«ãŠå ·äœçã«
説æããã å®éšäŸ ïŒ ã¹ãã¬ãããŸãã·ã³èªçºç³å°¿ç ã©ããã®æ°Žæ¶äœ
ããã³å骚ç¥çµãžã®ãœã«ãããŒã«ã®èç©ãäœäžãŸ
ãã¯é»å®³ãã掻æ§ã®æž¬å® ã¹ãã¬ãããŸãã·ã³èªçºç³å°¿ç ã©ããã®æ°Žæ¶äœ
ããã³å骚ç¥çµã®ãœã«ãããŒã«ã®èç©ã®äœäžãŸã
ã¯é»å®³ããèœåãè¡šïŒããã³è¡šïŒã«ç€ºãååç©ã«
ã€ããŠM.J.Peterson et alïŒMetabolismïŒVol
28ïŒNo.ïŒïŒSuppl.1ïŒAprilïŒïŒ1979ïŒ456ã461ã«èš
èŒã®æ¹æ³ã«ããè©Šéšãããå¯Ÿç §ååç©ãšããŠã¯ã
åè¿°ããç¹èš±åºé¡å ¬éæå53幎第53653å·ã«èšèŒ
ãããŠãã代衚çååç©ïŒâãã«ãªãâã¹ãã
ãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²â
ãžãªã³ãéžæãããå®éšã¯ãã©ããã®æ°Žæ¶äœãã
ã³å骚ç¥çµäžã®ãœã«ãããŒã«èç©éããç³å°¿ç èª
çºåŸ28æéã«ããã枬å®ããããšã«ãããããªã
ãããããªãã¡ãã¹ãã¬ãããŸãã·ã³æäžåŸã
ïŒïŒïŒïŒ25æéåŸã«ãè¡šïŒããã³è¡šïŒã«ç€ºãåå
ç©ãããããã®æäžéã«ãŠæäžãããããªãã¡è¡š
ïŒã®å®éšã¯0.2mgïŒKgãïŒmgïŒKgããã³ïŒmgïŒKg
ã®æäžéã§ã®å®éšã§ãè¡šïŒã¯10mgïŒKgã®æäžéã§
ã®å®éšã§ãããçµæãè¡šïŒããã³è¡šïŒã«ç€ºããè¡š
ïŒããã³è¡šïŒã«ãããæå¶çãšã¯ãã³ã³ãããŒã«
ãšæ¯èŒããŠè©Šéšååç©ã«ãã€ãŠéæãããé»å®³ïŒ
ã瀺ãã ãªãè¡šïŒããã³è¡šïŒã«ãããååç©ã«ãããŠã
ïŒâãã«ãªãâïŒâã¡ãã«âã¹ããâãã¯ããã³
âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³ãã
ã³ïŒâã¯ããâïŒâã¡ãã«âã¹ããâãã¯ããã³
âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³ã¯ã
åŸè¿°ã®åæäŸïŒããã³åæäŸïŒã«ãããŠåªå¢ã«ç
æããååç©ãããªãã¡ãããããèç¹233ã235
âãèç¹283ã285âãæããçµæ¶ãæå³ããã
ãè¡šã
ãè¡šã
ãè¡šã
å®éšäŸ ïŒ
ã©ããã¬ã©ã¯ããŒã¹çœå
éã«å¯Ÿããå¹æ
ïŒé±ä»€éæ§SDã©ããã䜿çšãã30ïŒ
ã¬ã©ã¯ã
ãŒã¹å«æç²æ«é£çµŠé€äžã«ãããŠãïŒâãã«ãªãâ
ã¹ããâãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ
2â²ïŒ5â²âãžãªã³ïŒå¯Ÿç §ååç©ïŒããã³ïŒâã¯ãã
âïŒïŒïŒâãžã¡ãã«âã¹ããâãã¯ããã³âïŒïŒ
4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³ïŒæ¬çºæå
åç©ïŒãããããïŒæ¥ïŒåãïŒïŒïŒïŒ25mgïŒKg匷
å¶çµå£æäžãããã¬ã©ã¯ããŒã¹é£çµŠé€16æ¥ç®ïŒæ
çµæäž24æéåŸïŒã«ãæ°Žæ¶äœæ··æ¿ç¶æ ã芳å¯ãã
æŽã«æ°Žæ¶äœãå骚ç¥çµæåºããç³è³ªã®å«éã枬å®
ããã 枬å®çµæ (1) çœå éçºçæå¶å¹æ çµæãå³ïŒåã³è¡šïŒã«ç€ºãã å³ïŒã¯ãã¬ã©ã¯ããŒã¹çœå éã©ããã«ãããŠå¯Ÿ
ç §ååç©ãšæ¬çºæååç©ã®çœå éã«å¯Ÿããå¹æã
瀺ãã暪軞ã¯30ïŒ ã¬ã©ã¯ããŒã¹é£æäžéå§åŸã®æ¥
æ°ã瀺ãã瞊軞ã¯çœå éåºçŸçã瀺ããå³ïŒäžã
âå°ã¯ãã³ã³ãããŒã«ã®å Žåã âå°ã¯ãå¯Ÿç §ååç©ïŒmgïŒKgæäžã®å Žåã â²å°ã¯ãå¯Ÿç §ååç©ïŒmgïŒKgæäžã®å Žåã âå°ã¯ãæ¬çºæååç©ïŒmgïŒKgæäžã®å Žåãã瀺
ãã å³ïŒã§æãããªåŠããå¯Ÿç §çŸ€ïŒã³ã³ãããŒã«ïŒ
ã§ã¬ã©ã¯ããŒã¹é£çµŠé€ïŒæ¥ç®ããçœæ¿ãçããã®
ã«å¯Ÿããè¬ç©æäžçŸ€ã§ã¯ãçœå éçºçé 延ãŸãã¯
é»æ¢äœçšãèªããããããªããå³ïŒã«è¡šç€ºãããŠ
ããªãæäžéïŒå¯Ÿç §ååç©25mgïŒKgãæ¬çºæåå
ç©ïŒmgïŒKgã25mgïŒKgïŒã§ã¯ãã¬ã©ã¯ããŒã¹é£çµŠ
é€16æ¥ç®ã«ãããŠãæ°Žæ¶äœã®æ··æ¿ã¯èªããããªã
ã€ãã 次ã«ãè¡šïŒã«ãã¬ã©ã¯ããŒã¹é£çµŠé€16æ¥ç®ã«ã
ããŠãæ°Žæ¶äœæ··æ¿ç¶æ ãèçŒã§èŠ³å¯ããçµæã瀺
ããè¡šïŒã«ãããŠãâã¯æ··æ¿ãçããªãã€ãå Žå
ã瀺ããïŒïŒïŒã¯æ··æ¿ã®çšåºŠã瀺ãã
ãŒã¹å«æç²æ«é£çµŠé€äžã«ãããŠãïŒâãã«ãªãâ
ã¹ããâãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ
2â²ïŒ5â²âãžãªã³ïŒå¯Ÿç §ååç©ïŒããã³ïŒâã¯ãã
âïŒïŒïŒâãžã¡ãã«âã¹ããâãã¯ããã³âïŒïŒ
4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³ïŒæ¬çºæå
åç©ïŒãããããïŒæ¥ïŒåãïŒïŒïŒïŒ25mgïŒKg匷
å¶çµå£æäžãããã¬ã©ã¯ããŒã¹é£çµŠé€16æ¥ç®ïŒæ
çµæäž24æéåŸïŒã«ãæ°Žæ¶äœæ··æ¿ç¶æ ã芳å¯ãã
æŽã«æ°Žæ¶äœãå骚ç¥çµæåºããç³è³ªã®å«éã枬å®
ããã 枬å®çµæ (1) çœå éçºçæå¶å¹æ çµæãå³ïŒåã³è¡šïŒã«ç€ºãã å³ïŒã¯ãã¬ã©ã¯ããŒã¹çœå éã©ããã«ãããŠå¯Ÿ
ç §ååç©ãšæ¬çºæååç©ã®çœå éã«å¯Ÿããå¹æã
瀺ãã暪軞ã¯30ïŒ ã¬ã©ã¯ããŒã¹é£æäžéå§åŸã®æ¥
æ°ã瀺ãã瞊軞ã¯çœå éåºçŸçã瀺ããå³ïŒäžã
âå°ã¯ãã³ã³ãããŒã«ã®å Žåã âå°ã¯ãå¯Ÿç §ååç©ïŒmgïŒKgæäžã®å Žåã â²å°ã¯ãå¯Ÿç §ååç©ïŒmgïŒKgæäžã®å Žåã âå°ã¯ãæ¬çºæååç©ïŒmgïŒKgæäžã®å Žåãã瀺
ãã å³ïŒã§æãããªåŠããå¯Ÿç §çŸ€ïŒã³ã³ãããŒã«ïŒ
ã§ã¬ã©ã¯ããŒã¹é£çµŠé€ïŒæ¥ç®ããçœæ¿ãçããã®
ã«å¯Ÿããè¬ç©æäžçŸ€ã§ã¯ãçœå éçºçé 延ãŸãã¯
é»æ¢äœçšãèªããããããªããå³ïŒã«è¡šç€ºãããŠ
ããªãæäžéïŒå¯Ÿç §ååç©25mgïŒKgãæ¬çºæåå
ç©ïŒmgïŒKgã25mgïŒKgïŒã§ã¯ãã¬ã©ã¯ããŒã¹é£çµŠ
é€16æ¥ç®ã«ãããŠãæ°Žæ¶äœã®æ··æ¿ã¯èªããããªã
ã€ãã 次ã«ãè¡šïŒã«ãã¬ã©ã¯ããŒã¹é£çµŠé€16æ¥ç®ã«ã
ããŠãæ°Žæ¶äœæ··æ¿ç¶æ ãèçŒã§èŠ³å¯ããçµæã瀺
ããè¡šïŒã«ãããŠãâã¯æ··æ¿ãçããªãã€ãå Žå
ã瀺ããïŒïŒïŒã¯æ··æ¿ã®çšåºŠã瀺ãã
ãè¡šã
ãè¡šã
å³ïŒããã³è¡šïŒããæ¬çºæååç©ã¯ã察ç
§åå
ç©ãšæ¯èŒããŠåªããŠããããšãæçœã§ããã (2) æ°Žæ¶äœåã³å骚ç¥çµã«ãããã¬ã©ã¯ãããŒã«
èç©æå¶å¹æçµæãè¡šïŒã«ç€ºãã
ç©ãšæ¯èŒããŠåªããŠããããšãæçœã§ããã (2) æ°Žæ¶äœåã³å骚ç¥çµã«ãããã¬ã©ã¯ãããŒã«
èç©æå¶å¹æçµæãè¡šïŒã«ç€ºãã
ãè¡šã
è¡šïŒããæãããªåŠããæ¬çºæååç©ã¯ã察ç
§
ååç©ãšæ¯èŒããŠã¬ã©ã¯ãããŒã«èç©æå¶çã«ã
ããŠèããåªããŠãããç¹ã«å骚ç¥çµã«ãããŠ
ã¯ãå¯Ÿç §ååç©ã«æ¯ã¹ãïŒå以äžåªããŠããã å®éšäŸ ïŒ ã¢ã«ããŒã¹ ãªãã¯ã¿ãŒãŒé»å®³äœçš Haymanãã®æ¹æ³ãS.Hayman and J.K.
KinoshitaïŒJournal of Biological Chemiâ
stryïŒVol.240ïŒ877ïŒ1965ïŒãã«æºããŠã¢ã«ããŒã¹
ãªãã¯ã¿ãŒãŒã調æŽããGabbayãã®æ¹æ³ãK.
H.Gabbay and J.H.KinoshitaïŒMethod in
EnzymologyïŒVol.41ïŒ159ïŒ1975ïŒãã«æºããŠã¢
ã«ããŒã¹ ãªãã¯ã¿ãŒãŒé»å®³æŽ»æ§ã枬å®ããã ãã®çµæãè¡š5.ã«ç€ºããè¡šïŒäžãID50ãšã¯ãã¢
ã«ããŒã¹ ãªãã¯ã¿ãŒãŒ50ïŒ é»å®³æ¿åºŠã瀺ãã
ååç©ãšæ¯èŒããŠã¬ã©ã¯ãããŒã«èç©æå¶çã«ã
ããŠèããåªããŠãããç¹ã«å骚ç¥çµã«ãããŠ
ã¯ãå¯Ÿç §ååç©ã«æ¯ã¹ãïŒå以äžåªããŠããã å®éšäŸ ïŒ ã¢ã«ããŒã¹ ãªãã¯ã¿ãŒãŒé»å®³äœçš Haymanãã®æ¹æ³ãS.Hayman and J.K.
KinoshitaïŒJournal of Biological Chemiâ
stryïŒVol.240ïŒ877ïŒ1965ïŒãã«æºããŠã¢ã«ããŒã¹
ãªãã¯ã¿ãŒãŒã調æŽããGabbayãã®æ¹æ³ãK.
H.Gabbay and J.H.KinoshitaïŒMethod in
EnzymologyïŒVol.41ïŒ159ïŒ1975ïŒãã«æºããŠã¢
ã«ããŒã¹ ãªãã¯ã¿ãŒãŒé»å®³æŽ»æ§ã枬å®ããã ãã®çµæãè¡š5.ã«ç€ºããè¡šïŒäžãID50ãšã¯ãã¢
ã«ããŒã¹ ãªãã¯ã¿ãŒãŒ50ïŒ é»å®³æ¿åºŠã瀺ãã
ãè¡šã
æ¬çºæã«ãã€ãŠæäŸãããååç©ã¯ãé£æ²»æ§çŸ
æ£ã§ããç³å°¿ç ã«ãšããªãçš®ã ã®æ ¢æ§çç¶ãå䜵
çç¶ãäŸãã°ç³å°¿ç æ§çœå éãæ«æ¢¢ç¥çµçïŒããŠ
ãŒããããŒïŒãªã©ã®ç³å°¿ç æ§ç¥çµé害ãç³å°¿ç ã«
èµ·å ããçš®ã ã®åè硬åæ§è¡ç®¡é害ãããã³ç³å°¿
ç æ§è çãç³å°¿ç æ§ç¶²èçãªã©ã®çŽ°å°è¡ç®¡é害ãª
ã©ã®æ²»çã»äºé²ã«æçšã§ããã®ã§ãæ¬çºæã¯æ¥µã
ãŠäŸ¡å€ã®é«ããã®ã§ããã æ¬çºæååç©ãç³å°¿ç ã«ãšããªãçš®ã ã®æ ¢æ§ç
ç¶ãå䜵çç¶ã®æ²»çã»äºé²å€ãšããŠäœ¿çšããå Žå
ã¯ãçµå£æäžè¥ããã¯éçµå£æäžïŒçèå ãç®
äžãéèå çïŒã«ããæäžããããæäžéã¯ãçŸ
æ£ã®çžéãçç¶ã®çšåºŠã幎什ãªã©ã«ããç°ãªãã
ç¹ã«éå®ãããªãããéåžžæ人ïŒæ¥ãããçŽïŒã
100mgã奜ãŸããã¯çŽïŒã20mgã§ããã æ¬çºæã®ååç©ã補å€åããããã«ã¯ã補å€ã®
æè¡åéã«ãããéåžžã®æ¹æ³ã§é å€ãé¡ç²å€ãæ£
å€ãã«ãã»ã«å€ã泚å°å€ãåè¬çã®å€åãšããã ããªãã¡ãçµå£çšåºåœ¢è£œå€ã調補ããå Žåã¯äž»
è¬ã«è³Šåœ¢å€ãæŽã«å¿ èŠã«å¿ããŠçµåå€ã厩å£å€ã
æ»æ²¢å€ãçè²å€ãç¯å³ç¯èå€ãªã©ãå ããåŸãåžž
æ³ã«ããé å€ã被èŠé å€ãé¡ç²å€ãæ£å€ãã«ãã»
ã«å€ãªã©ãšããã 賊圢è¬ãšããŠã¯ãäŸãã°ä¹³ç³ãã³ãŒã³ã¹ã¿ãŒ
ããçœç³ããããŠç³ããœã«ããããçµæ¶ã»ã«ããŒ
ã¹ãªã©ããçµåå€ãšããŠã¯äŸãã°ãããªããã«ã¢
ã«ã³ãŒã«ãããªãããŒã«ãšãŒãã«ããšãã«ã»ã«ã
ãŒã¹ãã¡ãã«ã»ã«ããŒã¹ãã¢ã©ãã¢ãŽã ããã©ã¬
ã³ãããŒã©ãã³ãã·ãšã©ãã¯ãããããã·ããã
ã«ã»ã«ããŒã¹ãããããã·ãããã«ã¹ã¿ãŒããã
ãªããã«ãããªãã³ãªã©ãã厩å£å€ãšããŠã¯äŸã
ã°ããã³ãã³ãå¯å€©ããŒã©ãã³æ«ãçµæ¶ã»ã«ããŒ
ã¹ãçé žã«ã«ã·ãŠã ãçé žæ°ŽçŽ ãããªãŠã ãã¯ãš
ã³é žã«ã«ã·ãŠã ãããã¹ããªã³ããã¯ãã³çãã
æ»æ²¢å€ãšããŠã¯äŸãã°ãã¹ãã¢ãªã³é žãã°ãã·ãŠ
ã ãã¿ã«ã¯ãããªãšãã¬ã³ã°ãªã³ãŒã«ãã·ãªã«ã
硬åæ€ç©æ²¹çããçè²å€ãšããŠã¯å»è¬åã«æ·»å ã
ãããšãèš±å¯ãããŠãããã®ããç¯å³ç¯èå€ãšã
ãŠã¯ãã³ã³ã¢æ«ãããã«è³ãè³éŠé žãããã«æ²¹ã
ç«è³ãæ¡ç®æ«çãçšããããããããã®é å€ãé¡
ç²å€ã«ã¯ç³è¡£ããŒã©ãã³è¡£ããã®ä»å¿ èŠã«ããé©
å®ã³ãŒãã€ã³ã°ããããšã¯ãã¡ããããã€ãããª
ãã 泚å°å€ã調補ããå Žåã«ã¯ãäž»è¬ã«å¿ èŠã«ãã
PH調æŽå€ãç·©è¡å€ãå®å®åå€ãä¿åå€ãªã©ãæ·»å
ããåžžæ³ã«ããç®äžãçèå ãéèå çšæ³šå°å€ãš
ããã 次ã«æ¬çºæã®çµå£æäžã§ã®æ¯æ§è©Šéšã®çµæãè¡š
ïŒã«ç€ºãã
æ£ã§ããç³å°¿ç ã«ãšããªãçš®ã ã®æ ¢æ§çç¶ãå䜵
çç¶ãäŸãã°ç³å°¿ç æ§çœå éãæ«æ¢¢ç¥çµçïŒããŠ
ãŒããããŒïŒãªã©ã®ç³å°¿ç æ§ç¥çµé害ãç³å°¿ç ã«
èµ·å ããçš®ã ã®åè硬åæ§è¡ç®¡é害ãããã³ç³å°¿
ç æ§è çãç³å°¿ç æ§ç¶²èçãªã©ã®çŽ°å°è¡ç®¡é害ãª
ã©ã®æ²»çã»äºé²ã«æçšã§ããã®ã§ãæ¬çºæã¯æ¥µã
ãŠäŸ¡å€ã®é«ããã®ã§ããã æ¬çºæååç©ãç³å°¿ç ã«ãšããªãçš®ã ã®æ ¢æ§ç
ç¶ãå䜵çç¶ã®æ²»çã»äºé²å€ãšããŠäœ¿çšããå Žå
ã¯ãçµå£æäžè¥ããã¯éçµå£æäžïŒçèå ãç®
äžãéèå çïŒã«ããæäžããããæäžéã¯ãçŸ
æ£ã®çžéãçç¶ã®çšåºŠã幎什ãªã©ã«ããç°ãªãã
ç¹ã«éå®ãããªãããéåžžæ人ïŒæ¥ãããçŽïŒã
100mgã奜ãŸããã¯çŽïŒã20mgã§ããã æ¬çºæã®ååç©ã補å€åããããã«ã¯ã補å€ã®
æè¡åéã«ãããéåžžã®æ¹æ³ã§é å€ãé¡ç²å€ãæ£
å€ãã«ãã»ã«å€ã泚å°å€ãåè¬çã®å€åãšããã ããªãã¡ãçµå£çšåºåœ¢è£œå€ã調補ããå Žåã¯äž»
è¬ã«è³Šåœ¢å€ãæŽã«å¿ èŠã«å¿ããŠçµåå€ã厩å£å€ã
æ»æ²¢å€ãçè²å€ãç¯å³ç¯èå€ãªã©ãå ããåŸãåžž
æ³ã«ããé å€ã被èŠé å€ãé¡ç²å€ãæ£å€ãã«ãã»
ã«å€ãªã©ãšããã 賊圢è¬ãšããŠã¯ãäŸãã°ä¹³ç³ãã³ãŒã³ã¹ã¿ãŒ
ããçœç³ããããŠç³ããœã«ããããçµæ¶ã»ã«ããŒ
ã¹ãªã©ããçµåå€ãšããŠã¯äŸãã°ãããªããã«ã¢
ã«ã³ãŒã«ãããªãããŒã«ãšãŒãã«ããšãã«ã»ã«ã
ãŒã¹ãã¡ãã«ã»ã«ããŒã¹ãã¢ã©ãã¢ãŽã ããã©ã¬
ã³ãããŒã©ãã³ãã·ãšã©ãã¯ãããããã·ããã
ã«ã»ã«ããŒã¹ãããããã·ãããã«ã¹ã¿ãŒããã
ãªããã«ãããªãã³ãªã©ãã厩å£å€ãšããŠã¯äŸã
ã°ããã³ãã³ãå¯å€©ããŒã©ãã³æ«ãçµæ¶ã»ã«ããŒ
ã¹ãçé žã«ã«ã·ãŠã ãçé žæ°ŽçŽ ãããªãŠã ãã¯ãš
ã³é žã«ã«ã·ãŠã ãããã¹ããªã³ããã¯ãã³çãã
æ»æ²¢å€ãšããŠã¯äŸãã°ãã¹ãã¢ãªã³é žãã°ãã·ãŠ
ã ãã¿ã«ã¯ãããªãšãã¬ã³ã°ãªã³ãŒã«ãã·ãªã«ã
硬åæ€ç©æ²¹çããçè²å€ãšããŠã¯å»è¬åã«æ·»å ã
ãããšãèš±å¯ãããŠãããã®ããç¯å³ç¯èå€ãšã
ãŠã¯ãã³ã³ã¢æ«ãããã«è³ãè³éŠé žãããã«æ²¹ã
ç«è³ãæ¡ç®æ«çãçšããããããããã®é å€ãé¡
ç²å€ã«ã¯ç³è¡£ããŒã©ãã³è¡£ããã®ä»å¿ èŠã«ããé©
å®ã³ãŒãã€ã³ã°ããããšã¯ãã¡ããããã€ãããª
ãã 泚å°å€ã調補ããå Žåã«ã¯ãäž»è¬ã«å¿ èŠã«ãã
PH調æŽå€ãç·©è¡å€ãå®å®åå€ãä¿åå€ãªã©ãæ·»å
ããåžžæ³ã«ããç®äžãçèå ãéèå çšæ³šå°å€ãš
ããã 次ã«æ¬çºæã®çµå£æäžã§ã®æ¯æ§è©Šéšã®çµæãè¡š
ïŒã«ç€ºãã
ãè¡šã
æ¬çºæååç©ã¯ãè¡šïŒããéåžžã«å®å
šæ§ã®é«ã
ååç©ã§ãããæ¬çºæååç©ãç³å°¿ç ã«ãšããªã
æ ¢æ§çç¶ã»å䜵çç¶ã®æ²»çã«çšããéãçŸæ£ã®æ§
質äžé·æé£çšãäœåãªãããããã®ã§ããããäž
è¿°ã®åŠãæ¬çºæååç©ã極ããŠå®å šæ§ã®é«ãããš
ã¯æ¥µããŠéèŠãªããšã§ããã 次ã«æ¬çºæååç©ã®åæäŸã瀺ãã åæäŸ ïŒ ïŒâãã«ãªãâïŒâã¡ãã«âã¹ããâãã¯ãã
ã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³ (1) ïŒâãã«ãªãâïŒâã¡ãã«âïŒâã¯ãããã³
ã®åæ ãã©ãŒãã«ãªãããšããŒã«11.2gïŒ0.1ã¢ã«ïŒã
ãã³ã¯ããã³é ž17.2gïŒ0.2ã¢ã«ïŒãããªãªã³é ž100
mlã«æº¶è§£ããæ¿ããæªæäž120âã§ïŒæéåå¿ã
ãããå·åŽåŸæ°·ãš2Nâæ°Žé žåãããªãŠã 450mlã«
泚ããã¯ãããã«ã 500mlã§æœåºãããã¯ããã
ã«ã å±€ãã2Nâæ°Žé žåãããªãŠã ã§æŽãã次ã
ã§æ°ŽæŽããåŸãç¡«é žãã°ãã·ãŠã ã§ä¹Ÿç¥ãã溶åª
ãçå»ãããæ®æž£ãïœâãããµã³çŽ10åéã§åçµ
æ¶ããŠæšé¡ã®ïŒâãã«ãªãâïŒâã¡ãã«âïŒâã¯
ãããã³5.8gïŒåç32ïŒ ïŒãåŸããèç¹ïŒ68ã69
â (2) ïŒâãã«ãªãâïŒâã¡ãã«âã¹ããâãã¯ã
ãã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³
ã®åæ (1)ã®æ¹æ³ã§åŸãããïŒâãã«ãªãâïŒâã¡ãã«
âïŒâã¯ãããã³10.8gïŒ0.06ã¢ã«ïŒãé ¢é žã¢ãã
120gãã·ã¢ã³åã«ãªãŠã 11.7gïŒ0.18ã¢ã«ïŒããã
ã³çé žã¢ã³ã¢ããŠã 37.4gïŒ0.39ã¢ã«ïŒã300mlãª
ãŒãã¯ã¬ãŒãã«ä»èŸŒã¿ã70âã24æéå ç±ãåå¿
ããããåå¿çµäºåŸãæ°Ž600mlã«ãšããããã®æº¶
液ãå¡©é žã§é žæ§ãšãããæåºããçµæ¶ãåãã
åŸãçµæ¶ã2Nâæ°Žé žåãããªãŠã 氎溶液600mlã«
溶ããã次ãã§ããã«æŽ»æ§çãå ããã掻æ§çã
å¥ããåŸã液ãå¡©é žã§é žæ§ãšããæåºçµæ¶ã
åããæ°ŽæŽåŸã也ç¥ãã次ãã§ãšãã«ã¢ã«ã³ãŒ
ã«ã§åçµæ¶ããŠã次ã«ç€ºãèç¹ãå çŽ åæå€ãæ
ããæšé¡ã®ïŒâãã«ãªãâïŒâã¡ãã«âã¹ããâ
ãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²â
ãžãªã³5.8gïŒåç39ïŒ ïŒãåŸãã èç¹ïŒ233ã235â å çŽ åæå€ïŒC12H11FN2O3ãšã㊠   çè«å€(%) 57.60 4.43 11.20 å®æž¬å€(%) 57.53 4.44 11.21 ãªããåçµæ¶æ¯æ¶²ãããèç¹230ã232âãæã
ãæšé¡ååç©ã®äžæ¹ã®ãžã¢ã¹ãã¬ãªããŒã§ããçµ
æ¶ãåŸãã åèšãšã®çµæ¶ã®æ¯çã¯10ïŒïŒã§ãã€ããããã
ã®ãžã¢ã¹ãã¬ãªããŒã®ãã¡ãåªå¢ã«è£œé ãããçµ
æ¶ãããªãã¡ãåèšã®èç¹233ã235âãæããçµ
æ¶ã®æ¹ãèç¹230ã232âãæããçµæ¶ã«ããã¹ãŠ
ãœã«ãããŒã«èç©æå¶çãªã©ã®æŽ»æ§ãïŒãïŒåé«
ãããšãå€æããŠããã åæäŸ ïŒ ïŒâã¯ããâïŒâã¡ãã«âã¹ããâãã¯ããã³
âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³ (1) ïŒâã¯ããâïŒâã¡ãã«âïŒâã¯ãããã³ã®
åæ åæäŸïŒã®(1)ã®æ¹æ³ãšåæ§ã®æäœã«ããæšé¡ã® ïŒâã¯ããâïŒâã¡ãã«âïŒâã¯ãããã³5.8g
ïŒåç30.0ïŒ ïŒãåŸããèç¹ïŒ100ã102â (2) ïŒâã¯ããâïŒâã¡ãã«âã¹ããâãã¯ãã
ã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³ã®
åæ (1)ã®æ¹æ³ã§åŸãããïŒâã¯ããâïŒâã¡ãã«â
ïŒâã¯ãããã³ãçšããŠãåæäŸïŒã®(2)ã®æ¹æ³ãš
åæ§ã®æäœã«ãã次ã«ç€ºãèç¹ãå çŽ åæå€ãæ
ããæšé¡ã®ïŒâã¯ããâïŒâã¡ãã«âã¹ããâ
ãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²â
ãžãªã³8.8gïŒåç55ïŒ ïŒãåŸãã èç¹ïŒ283ã285â å çŽ åæå€ïŒC12H11ClN2O3ãšã㊠   çè«å€(%) 4.05 4.16 10.50 å®æž¬å€(%) 54.10 3.71 10.55 ãªããåçµæ¶æ¯æ¶²ãããèç¹223ã228âãæã
ãæšé¡ååç©ã®äžæ¹ã®ãžã¢ã¹ãã¬ãªããŒã§ããçµ
æ¶ãåŸãã åèšãšã®çµæ¶ã®æ¯çã¯ïŒïŒïŒã§ãã€ããããã
ã®ãžã¢ã¹ãã¬ãªããŒã®ãã¡åªå¢ã«è£œé ãããçµ
æ¶ãããªãã¡ãåèšã®283ã285âãæããçµæ¶ã®
æ¹ããèç¹223ã228âãæããçµæ¶ã«æ¯ã¹ãŠãœã«
ãããŒã«èç©æå¶çãªã©ã®æŽ»æ§ãïŒãïŒåé«ãã
ãšãå€æããŠããã åæäŸ ïŒ ïŒâã¯ããâïŒïŒïŒâãžã¡ãã«âã¹ããâãã¯
ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãª
ã³ (1) ïŒâã¯ããâïŒïŒïŒâãžã¡ãã«âïŒâã¯ãã
ãã³ã®åæ ïŒâã¯ããâïŒâãã€ãããã·ã¢ã»ãããšãã³
34.6gïŒ0.203ã¢ã«ïŒãšã¢ã»ãã³15.5gïŒ0.258ã¢ã«ïŒ
ã200mlïŒåŸãã©ã¹ã³ã«ä»èŸŒã¿ããã³ãŒã³60mlã«
溶ããããã®æ··åç©ã«å®€æž©ã§ãããªãžã³4.1g
ïŒ0.0577ã¢ã«ïŒã滎äžãããïŒæéæªæããåŸã
æ°Žåé¢åšä»å·åŽç®¡ãã€ããéæµããåŸãã¢ã»ãã³
ïŒã12mlãè¿œå ããæŽã«ïŒæééæµãããåå¿åŸ
åå¿æ··åç©ã2NâNaOH150mlã§ïŒåæŽæµãæ°ŽæŽ
ããã次ãã§æŽã«2NâHClã§ïŒåæŽæµããæ°ŽæŽ
åŸMgSO4ã§ä¹Ÿç¥ãã溶åªãçå»åŸãç空èžçã
ãŠæšé¡ã®ïŒâã¯ããâïŒïŒïŒâãžã¡ãã«âïŒâã¯
ãããã³26.8gïŒåç62.6ïŒ ïŒãåŸãã沞ç¹95ã
100âïŒ0.2ã0.3mmïŒHg (2) ïŒâã¯ããâïŒïŒïŒâãžã¡ãã«âã¹ããâ
ãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²â
ãžãªã³ã®åæ (1)ã®æ¹æ³ã§åŸãããïŒâã¯ããâïŒïŒïŒâãžã¡
ãã«âïŒâã¯ãããã³10gïŒ0.0474molïŒãšã·ã¢ã³
åã«ãªãŠã ïŒKCNïŒ9.6gïŒ0.148molïŒãçé žã¢ã³
ã¢ããŠã ïŒïŒNH4ïŒ2CO3ïŒ30gïŒ0.313molïŒããã³
ã¢ã»ãã¢ãã190gã300mlãªãŒãã¯ã¬ãŒãã«ä»èŸŒ
ã¿ã70âã24æéã次ãã§110âã24æéå ç±ã
ããå·åŽåŸãæ°Ž950mlã«æº¶è§£ããæ¿å¡©é žã§é žæ§ãš
ãæåºããçµæ¶ãåãããçµæ¶ã2NâNaOH
氎溶液400mlã«ãšãããéãã液ãæ¿å¡©é žã§
é žæ§ãšããäžå€æŸçœ®ãããæåºçµæ¶ãåã也ç¥
ãããšãã«ã¢ã«ã³ãŒã«ã§åçµæ¶ããŠæšé¡ã®ïŒâã¯
ããâïŒïŒïŒâãžã¡ãã«âã¹ããâãã¯ããã³â
ïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³8.3g
ïŒåç61ïŒ ïŒãåŸãã èç¹ïŒ281ã283â å çŽ åæå€ïŒ    çè«å€(%) 55.60 4.66 9.77 å®æž¬å€(%) 55.72 4.78 10.17 åæäŸ ïŒ ã·ã¯ããããµã³ãã¹ããâïŒãâïŒâã¡ãã«â
ã¹ãããã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ
2â²ïŒ5â²âãžãªã³ (1) ã·ã¯ããããµã³ãã¹ããâïŒãâïŒâã¯ãã
ãã³ã®åæ æ°Žåé¢åšãä»ããïŒåŸå¹³åºãã©ã¹ã³ã«ãïŒâ
ãã€ãããã·âïŒâã¡ãã«ã¢ã»ãããšãã³8g
ïŒ0.06molïŒãã·ã¯ããããµãã³7.65g
ïŒ0.078molïŒãããã³ãã«ãšã³15mlãä»èŸŒã¿ã
宀枩äžãããªãžã³1.2gïŒ0.017molïŒã滎äžãã
30åãïŒæéæªæåŸã13æééæµãããåå¿çµ
äºåŸå·åŽãã2NâNaOH200mlã§æŽãã次ãã§
æ°ŽæŽããã次ã«2NâHClã§æŽæµãã次ãã§æ°Ž
æŽããåŸãMgSO4ã§ä¹Ÿç¥åŸã掻æ§çåŠçããã
éåŸæº¶åªãçå»ããæšé¡ã®ã·ã¯ããããµã³
ãã¹ããâïŒãâïŒâã¯ãããã³7.7gïŒåç55.8
ïŒ ïŒãåŸãã (2) ã·ã¯ããããµã³ãã¹ããâïŒãâïŒâã¡ãã«
âã¹ãããã¯ããã³âïŒïŒ4â²âã€ãããŸãªãž
ã³ãâ2â²ïŒ5â²âãžãªã³ã®åæ 100mlãªãŒãã¯ã¬ãŒãã«ã(1)ã®æ¹æ³ã§åŸããã
ã·ã¯ããããµã³ãã¹ããâïŒãâïŒâã¯ãããã³
4.6gïŒ0.02molïŒãã·ã¢ã³åã«ãªãŠã ïŒKCNïŒ4g
ïŒ0.06molïŒãçé žã¢ã³ã¢ããŠã ïŒïŒNH4ïŒ2CO3ïŒ
12.6gïŒ0.13molïŒãããã³é ¢é žã¢ããïŒCH3
CONH2ïŒ80gãä»èŸŒã¿ã60â24æéã次ãã§110
â24æéåå¿ããããå·åŽåŸåå¿æ··åç©ãæ°Ž400
mlã«æº¶è§£ããåŸãæ¿å¡©é žãå ãé žæ§ã«ããæåºã
ãçµæ¶ãåãããçµæ¶ãæŽã«2NâNaOH200ml
ã«ãšãããéãã液ãæ¿å¡©é žã§é žæ§ãšããæ
åºããçµæ¶ãåãã也ç¥ããããšã¿ããŒã«ã«ã
ãåçµæ¶ããæšé¡ã®ã·ã¯ããããµã³ãã¹ããâ
ïŒãâïŒâã¡ãã«âã¹ãããã¯ããã³âïŒïŒ4â²â
ã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³1.8gïŒåç30ïŒ ïŒ
ãåŸãã èç¹ïŒ267ã269â å çŽ åæå€ïŒC17H20N2O3ãšã㊠   çè«å€(%) 67.97 6.71 9.32 å®æž¬å€(%) 67.25 6.97 8.77 åæäŸ ïŒ ïŒâã¯ããâïŒïŒïŒâãžã¡ãã«âã¹ããâãã
ã³ãŸãã©ã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²â
ãžãªã³ (1) ïŒâã¯ããâïŒïŒïŒâãžã¡ãã«âïŒâãã³ãŸ
ãã©ãã³ã®åæ 100mlã®ç¡æ°Žãšã¿ããŒã«ã«æ°·å·æªæäžã3gã®é
å±ãããªãŠã ãå ããŠæº¶è§£ããã次ãã§å ç±éæµ
äžïŒå æž©80âïŒãããã«ïŒâã¯ããâïŒâïŒïŒâã
ãã¢ã€ãœãããªã«ïŒããšããŒã«12.5gïŒ0.045molïŒ
ã60mlã®ãã³ãŒã³ã«æº¶è§£ãããã®ãçŽ15åéã«ã
ãã€ãŠæ»Žå ããã滎å çµäºåŸ30ã60åéå ç±æªæ
ããåŸãåå¿æ¶²ãçŽ1/3éã«æžå§æ¿çž®ãã倧éã®
æ°Žãå ããŠåžéåŸãšãŒãã«æœåºããããšãŒãã«å±€
ãæ°ŽæŽåŸæžå§æ¿çž®ä¹Ÿåºããæšé¡ã®ïŒâã¯ããâ
ïŒïŒïŒâãžã¡ãã«âïŒâãã³ãŸãã©ã³ã®ç²çµæ¶
10gãåŸãã次ãã§æŽã«ã¡ã¿ããŒã«ã§åçµæ¶ãã
æšé¡ååç©7.3gïŒåç82.5ïŒ ïŒã®ç¡è²æ±ç¶æ¶ãåŸ
ãã èç¹ïŒ73.5ã74.5â (2) ïŒâã¯ããâïŒïŒïŒâãžã¡ãã«âã¹ããâ
ããã³ãŸãã©ã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ
2â²ïŒ5â²âãžãªã³ã®åæ (1)ã®æ¹æ³ã«ãã€ãŠåŸãããïŒâã¯ããâïŒïŒïŒ
âãžã¡ãã«âïŒâãã³ãŸãã©ã³6.9gïŒ0.035ã¢ã«ïŒã
ã·ã¢ã³åã«ãªãŠã ïŒKCNïŒ7.0gïŒ0.107ã¢ã«ïŒãç
é žã¢ã³ã¢ããŠã ïŒïŒNH4ïŒ2CO3ïŒ20gïŒ0.21ã¢ã«ïŒ
ããã³é ¢é žã¢ãã70gã油济äžã§85ã95âã§20æ
éã次ãã§105ã110âã§ïŒæéåå¿ããããåå¿
æ··åç©ãæ°·æ°Žã«æ³šãã§æº¶è§£åŸãå¡©é žé žæ§ãšããçŽ
ïŒæéæªæããæåºããçµæ¶ãåããã液ã¯
é ¢é žãšãã«ã§æœåºãããæåºããçµæ¶ãšé ¢é žãšã
ã«å±€ãããããå ç±éæµããé ¢é žãšãã«äžæº¶ç©ã
å»ãããé ¢é žãšãã«å¯æº¶éšã¯ãæ¿çž®åŸã¡ã¿ããŒ
ã«ã§åçµæ¶ããæšé¡ååç©ïŒâã¯ããâïŒïŒïŒâ
ãžã¡ãã«âã¹ããâããã³ãŸãã©ã³âïŒïŒ4â²âã€
ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³5.63gïŒåç60.3
ïŒ ïŒãåŸãã èç¹ïŒ228.5ã229â å çŽ åæå€ïŒ    çè«å€(%) 54.04 4.16 10.50 å®æž¬å€(%) 54.14 4.05 10.52 åæäŸ ïŒã30 åæäŸïŒãïŒã®æ¹æ³ã«æºããæ¹æ³ã«ãã次ã®è¡š
ïŒã«ç€ºãããååç©ãåŸãããã äœãè¡šïŒã«ãããŠãæ§é åŒäžã«ã¿ãããX1ã
ãã³X2ã®çœ®æåºã®äœçœ®ã¯ãïœïŒïŒã®å ŽåãšïœïŒ
ïŒã®å Žåãšã§ç°ãªãããäžèšã«ç€ºãåŠãçªå·ã«åº
ã¥ããŠçœ®æåºã®äœçœ®ã瀺ãã ïŒïŒïœïŒïŒã®å Žå ïŒïŒïœïŒïŒã®å Žå
ååç©ã§ãããæ¬çºæååç©ãç³å°¿ç ã«ãšããªã
æ ¢æ§çç¶ã»å䜵çç¶ã®æ²»çã«çšããéãçŸæ£ã®æ§
質äžé·æé£çšãäœåãªãããããã®ã§ããããäž
è¿°ã®åŠãæ¬çºæååç©ã極ããŠå®å šæ§ã®é«ãããš
ã¯æ¥µããŠéèŠãªããšã§ããã 次ã«æ¬çºæååç©ã®åæäŸã瀺ãã åæäŸ ïŒ ïŒâãã«ãªãâïŒâã¡ãã«âã¹ããâãã¯ãã
ã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³ (1) ïŒâãã«ãªãâïŒâã¡ãã«âïŒâã¯ãããã³
ã®åæ ãã©ãŒãã«ãªãããšããŒã«11.2gïŒ0.1ã¢ã«ïŒã
ãã³ã¯ããã³é ž17.2gïŒ0.2ã¢ã«ïŒãããªãªã³é ž100
mlã«æº¶è§£ããæ¿ããæªæäž120âã§ïŒæéåå¿ã
ãããå·åŽåŸæ°·ãš2Nâæ°Žé žåãããªãŠã 450mlã«
泚ããã¯ãããã«ã 500mlã§æœåºãããã¯ããã
ã«ã å±€ãã2Nâæ°Žé žåãããªãŠã ã§æŽãã次ã
ã§æ°ŽæŽããåŸãç¡«é žãã°ãã·ãŠã ã§ä¹Ÿç¥ãã溶åª
ãçå»ãããæ®æž£ãïœâãããµã³çŽ10åéã§åçµ
æ¶ããŠæšé¡ã®ïŒâãã«ãªãâïŒâã¡ãã«âïŒâã¯
ãããã³5.8gïŒåç32ïŒ ïŒãåŸããèç¹ïŒ68ã69
â (2) ïŒâãã«ãªãâïŒâã¡ãã«âã¹ããâãã¯ã
ãã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³
ã®åæ (1)ã®æ¹æ³ã§åŸãããïŒâãã«ãªãâïŒâã¡ãã«
âïŒâã¯ãããã³10.8gïŒ0.06ã¢ã«ïŒãé ¢é žã¢ãã
120gãã·ã¢ã³åã«ãªãŠã 11.7gïŒ0.18ã¢ã«ïŒããã
ã³çé žã¢ã³ã¢ããŠã 37.4gïŒ0.39ã¢ã«ïŒã300mlãª
ãŒãã¯ã¬ãŒãã«ä»èŸŒã¿ã70âã24æéå ç±ãåå¿
ããããåå¿çµäºåŸãæ°Ž600mlã«ãšããããã®æº¶
液ãå¡©é žã§é žæ§ãšãããæåºããçµæ¶ãåãã
åŸãçµæ¶ã2Nâæ°Žé žåãããªãŠã 氎溶液600mlã«
溶ããã次ãã§ããã«æŽ»æ§çãå ããã掻æ§çã
å¥ããåŸã液ãå¡©é žã§é žæ§ãšããæåºçµæ¶ã
åããæ°ŽæŽåŸã也ç¥ãã次ãã§ãšãã«ã¢ã«ã³ãŒ
ã«ã§åçµæ¶ããŠã次ã«ç€ºãèç¹ãå çŽ åæå€ãæ
ããæšé¡ã®ïŒâãã«ãªãâïŒâã¡ãã«âã¹ããâ
ãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²â
ãžãªã³5.8gïŒåç39ïŒ ïŒãåŸãã èç¹ïŒ233ã235â å çŽ åæå€ïŒC12H11FN2O3ãšã㊠   çè«å€(%) 57.60 4.43 11.20 å®æž¬å€(%) 57.53 4.44 11.21 ãªããåçµæ¶æ¯æ¶²ãããèç¹230ã232âãæã
ãæšé¡ååç©ã®äžæ¹ã®ãžã¢ã¹ãã¬ãªããŒã§ããçµ
æ¶ãåŸãã åèšãšã®çµæ¶ã®æ¯çã¯10ïŒïŒã§ãã€ããããã
ã®ãžã¢ã¹ãã¬ãªããŒã®ãã¡ãåªå¢ã«è£œé ãããçµ
æ¶ãããªãã¡ãåèšã®èç¹233ã235âãæããçµ
æ¶ã®æ¹ãèç¹230ã232âãæããçµæ¶ã«ããã¹ãŠ
ãœã«ãããŒã«èç©æå¶çãªã©ã®æŽ»æ§ãïŒãïŒåé«
ãããšãå€æããŠããã åæäŸ ïŒ ïŒâã¯ããâïŒâã¡ãã«âã¹ããâãã¯ããã³
âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³ (1) ïŒâã¯ããâïŒâã¡ãã«âïŒâã¯ãããã³ã®
åæ åæäŸïŒã®(1)ã®æ¹æ³ãšåæ§ã®æäœã«ããæšé¡ã® ïŒâã¯ããâïŒâã¡ãã«âïŒâã¯ãããã³5.8g
ïŒåç30.0ïŒ ïŒãåŸããèç¹ïŒ100ã102â (2) ïŒâã¯ããâïŒâã¡ãã«âã¹ããâãã¯ãã
ã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³ã®
åæ (1)ã®æ¹æ³ã§åŸãããïŒâã¯ããâïŒâã¡ãã«â
ïŒâã¯ãããã³ãçšããŠãåæäŸïŒã®(2)ã®æ¹æ³ãš
åæ§ã®æäœã«ãã次ã«ç€ºãèç¹ãå çŽ åæå€ãæ
ããæšé¡ã®ïŒâã¯ããâïŒâã¡ãã«âã¹ããâ
ãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²â
ãžãªã³8.8gïŒåç55ïŒ ïŒãåŸãã èç¹ïŒ283ã285â å çŽ åæå€ïŒC12H11ClN2O3ãšã㊠   çè«å€(%) 4.05 4.16 10.50 å®æž¬å€(%) 54.10 3.71 10.55 ãªããåçµæ¶æ¯æ¶²ãããèç¹223ã228âãæã
ãæšé¡ååç©ã®äžæ¹ã®ãžã¢ã¹ãã¬ãªããŒã§ããçµ
æ¶ãåŸãã åèšãšã®çµæ¶ã®æ¯çã¯ïŒïŒïŒã§ãã€ããããã
ã®ãžã¢ã¹ãã¬ãªããŒã®ãã¡åªå¢ã«è£œé ãããçµ
æ¶ãããªãã¡ãåèšã®283ã285âãæããçµæ¶ã®
æ¹ããèç¹223ã228âãæããçµæ¶ã«æ¯ã¹ãŠãœã«
ãããŒã«èç©æå¶çãªã©ã®æŽ»æ§ãïŒãïŒåé«ãã
ãšãå€æããŠããã åæäŸ ïŒ ïŒâã¯ããâïŒïŒïŒâãžã¡ãã«âã¹ããâãã¯
ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãª
ã³ (1) ïŒâã¯ããâïŒïŒïŒâãžã¡ãã«âïŒâã¯ãã
ãã³ã®åæ ïŒâã¯ããâïŒâãã€ãããã·ã¢ã»ãããšãã³
34.6gïŒ0.203ã¢ã«ïŒãšã¢ã»ãã³15.5gïŒ0.258ã¢ã«ïŒ
ã200mlïŒåŸãã©ã¹ã³ã«ä»èŸŒã¿ããã³ãŒã³60mlã«
溶ããããã®æ··åç©ã«å®€æž©ã§ãããªãžã³4.1g
ïŒ0.0577ã¢ã«ïŒã滎äžãããïŒæéæªæããåŸã
æ°Žåé¢åšä»å·åŽç®¡ãã€ããéæµããåŸãã¢ã»ãã³
ïŒã12mlãè¿œå ããæŽã«ïŒæééæµãããåå¿åŸ
åå¿æ··åç©ã2NâNaOH150mlã§ïŒåæŽæµãæ°ŽæŽ
ããã次ãã§æŽã«2NâHClã§ïŒåæŽæµããæ°ŽæŽ
åŸMgSO4ã§ä¹Ÿç¥ãã溶åªãçå»åŸãç空èžçã
ãŠæšé¡ã®ïŒâã¯ããâïŒïŒïŒâãžã¡ãã«âïŒâã¯
ãããã³26.8gïŒåç62.6ïŒ ïŒãåŸãã沞ç¹95ã
100âïŒ0.2ã0.3mmïŒHg (2) ïŒâã¯ããâïŒïŒïŒâãžã¡ãã«âã¹ããâ
ãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²â
ãžãªã³ã®åæ (1)ã®æ¹æ³ã§åŸãããïŒâã¯ããâïŒïŒïŒâãžã¡
ãã«âïŒâã¯ãããã³10gïŒ0.0474molïŒãšã·ã¢ã³
åã«ãªãŠã ïŒKCNïŒ9.6gïŒ0.148molïŒãçé žã¢ã³
ã¢ããŠã ïŒïŒNH4ïŒ2CO3ïŒ30gïŒ0.313molïŒããã³
ã¢ã»ãã¢ãã190gã300mlãªãŒãã¯ã¬ãŒãã«ä»èŸŒ
ã¿ã70âã24æéã次ãã§110âã24æéå ç±ã
ããå·åŽåŸãæ°Ž950mlã«æº¶è§£ããæ¿å¡©é žã§é žæ§ãš
ãæåºããçµæ¶ãåãããçµæ¶ã2NâNaOH
氎溶液400mlã«ãšãããéãã液ãæ¿å¡©é žã§
é žæ§ãšããäžå€æŸçœ®ãããæåºçµæ¶ãåã也ç¥
ãããšãã«ã¢ã«ã³ãŒã«ã§åçµæ¶ããŠæšé¡ã®ïŒâã¯
ããâïŒïŒïŒâãžã¡ãã«âã¹ããâãã¯ããã³â
ïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³8.3g
ïŒåç61ïŒ ïŒãåŸãã èç¹ïŒ281ã283â å çŽ åæå€ïŒ    çè«å€(%) 55.60 4.66 9.77 å®æž¬å€(%) 55.72 4.78 10.17 åæäŸ ïŒ ã·ã¯ããããµã³ãã¹ããâïŒãâïŒâã¡ãã«â
ã¹ãããã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ
2â²ïŒ5â²âãžãªã³ (1) ã·ã¯ããããµã³ãã¹ããâïŒãâïŒâã¯ãã
ãã³ã®åæ æ°Žåé¢åšãä»ããïŒåŸå¹³åºãã©ã¹ã³ã«ãïŒâ
ãã€ãããã·âïŒâã¡ãã«ã¢ã»ãããšãã³8g
ïŒ0.06molïŒãã·ã¯ããããµãã³7.65g
ïŒ0.078molïŒãããã³ãã«ãšã³15mlãä»èŸŒã¿ã
宀枩äžãããªãžã³1.2gïŒ0.017molïŒã滎äžãã
30åãïŒæéæªæåŸã13æééæµãããåå¿çµ
äºåŸå·åŽãã2NâNaOH200mlã§æŽãã次ãã§
æ°ŽæŽããã次ã«2NâHClã§æŽæµãã次ãã§æ°Ž
æŽããåŸãMgSO4ã§ä¹Ÿç¥åŸã掻æ§çåŠçããã
éåŸæº¶åªãçå»ããæšé¡ã®ã·ã¯ããããµã³
ãã¹ããâïŒãâïŒâã¯ãããã³7.7gïŒåç55.8
ïŒ ïŒãåŸãã (2) ã·ã¯ããããµã³ãã¹ããâïŒãâïŒâã¡ãã«
âã¹ãããã¯ããã³âïŒïŒ4â²âã€ãããŸãªãž
ã³ãâ2â²ïŒ5â²âãžãªã³ã®åæ 100mlãªãŒãã¯ã¬ãŒãã«ã(1)ã®æ¹æ³ã§åŸããã
ã·ã¯ããããµã³ãã¹ããâïŒãâïŒâã¯ãããã³
4.6gïŒ0.02molïŒãã·ã¢ã³åã«ãªãŠã ïŒKCNïŒ4g
ïŒ0.06molïŒãçé žã¢ã³ã¢ããŠã ïŒïŒNH4ïŒ2CO3ïŒ
12.6gïŒ0.13molïŒãããã³é ¢é žã¢ããïŒCH3
CONH2ïŒ80gãä»èŸŒã¿ã60â24æéã次ãã§110
â24æéåå¿ããããå·åŽåŸåå¿æ··åç©ãæ°Ž400
mlã«æº¶è§£ããåŸãæ¿å¡©é žãå ãé žæ§ã«ããæåºã
ãçµæ¶ãåãããçµæ¶ãæŽã«2NâNaOH200ml
ã«ãšãããéãã液ãæ¿å¡©é žã§é žæ§ãšããæ
åºããçµæ¶ãåãã也ç¥ããããšã¿ããŒã«ã«ã
ãåçµæ¶ããæšé¡ã®ã·ã¯ããããµã³ãã¹ããâ
ïŒãâïŒâã¡ãã«âã¹ãããã¯ããã³âïŒïŒ4â²â
ã€ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³1.8gïŒåç30ïŒ ïŒ
ãåŸãã èç¹ïŒ267ã269â å çŽ åæå€ïŒC17H20N2O3ãšã㊠   çè«å€(%) 67.97 6.71 9.32 å®æž¬å€(%) 67.25 6.97 8.77 åæäŸ ïŒ ïŒâã¯ããâïŒïŒïŒâãžã¡ãã«âã¹ããâãã
ã³ãŸãã©ã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ5â²â
ãžãªã³ (1) ïŒâã¯ããâïŒïŒïŒâãžã¡ãã«âïŒâãã³ãŸ
ãã©ãã³ã®åæ 100mlã®ç¡æ°Žãšã¿ããŒã«ã«æ°·å·æªæäžã3gã®é
å±ãããªãŠã ãå ããŠæº¶è§£ããã次ãã§å ç±éæµ
äžïŒå æž©80âïŒãããã«ïŒâã¯ããâïŒâïŒïŒâã
ãã¢ã€ãœãããªã«ïŒããšããŒã«12.5gïŒ0.045molïŒ
ã60mlã®ãã³ãŒã³ã«æº¶è§£ãããã®ãçŽ15åéã«ã
ãã€ãŠæ»Žå ããã滎å çµäºåŸ30ã60åéå ç±æªæ
ããåŸãåå¿æ¶²ãçŽ1/3éã«æžå§æ¿çž®ãã倧éã®
æ°Žãå ããŠåžéåŸãšãŒãã«æœåºããããšãŒãã«å±€
ãæ°ŽæŽåŸæžå§æ¿çž®ä¹Ÿåºããæšé¡ã®ïŒâã¯ããâ
ïŒïŒïŒâãžã¡ãã«âïŒâãã³ãŸãã©ã³ã®ç²çµæ¶
10gãåŸãã次ãã§æŽã«ã¡ã¿ããŒã«ã§åçµæ¶ãã
æšé¡ååç©7.3gïŒåç82.5ïŒ ïŒã®ç¡è²æ±ç¶æ¶ãåŸ
ãã èç¹ïŒ73.5ã74.5â (2) ïŒâã¯ããâïŒïŒïŒâãžã¡ãã«âã¹ããâ
ããã³ãŸãã©ã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ
2â²ïŒ5â²âãžãªã³ã®åæ (1)ã®æ¹æ³ã«ãã€ãŠåŸãããïŒâã¯ããâïŒïŒïŒ
âãžã¡ãã«âïŒâãã³ãŸãã©ã³6.9gïŒ0.035ã¢ã«ïŒã
ã·ã¢ã³åã«ãªãŠã ïŒKCNïŒ7.0gïŒ0.107ã¢ã«ïŒãç
é žã¢ã³ã¢ããŠã ïŒïŒNH4ïŒ2CO3ïŒ20gïŒ0.21ã¢ã«ïŒ
ããã³é ¢é žã¢ãã70gã油济äžã§85ã95âã§20æ
éã次ãã§105ã110âã§ïŒæéåå¿ããããåå¿
æ··åç©ãæ°·æ°Žã«æ³šãã§æº¶è§£åŸãå¡©é žé žæ§ãšããçŽ
ïŒæéæªæããæåºããçµæ¶ãåããã液ã¯
é ¢é žãšãã«ã§æœåºãããæåºããçµæ¶ãšé ¢é žãšã
ã«å±€ãããããå ç±éæµããé ¢é žãšãã«äžæº¶ç©ã
å»ãããé ¢é žãšãã«å¯æº¶éšã¯ãæ¿çž®åŸã¡ã¿ããŒ
ã«ã§åçµæ¶ããæšé¡ååç©ïŒâã¯ããâïŒïŒïŒâ
ãžã¡ãã«âã¹ããâããã³ãŸãã©ã³âïŒïŒ4â²âã€
ãããŸãªãžã³ãâ2â²ïŒ5â²âãžãªã³5.63gïŒåç60.3
ïŒ ïŒãåŸãã èç¹ïŒ228.5ã229â å çŽ åæå€ïŒ    çè«å€(%) 54.04 4.16 10.50 å®æž¬å€(%) 54.14 4.05 10.52 åæäŸ ïŒã30 åæäŸïŒãïŒã®æ¹æ³ã«æºããæ¹æ³ã«ãã次ã®è¡š
ïŒã«ç€ºãããååç©ãåŸãããã äœãè¡šïŒã«ãããŠãæ§é åŒäžã«ã¿ãããX1ã
ãã³X2ã®çœ®æåºã®äœçœ®ã¯ãïœïŒïŒã®å ŽåãšïœïŒ
ïŒã®å Žåãšã§ç°ãªãããäžèšã«ç€ºãåŠãçªå·ã«åº
ã¥ããŠçœ®æåºã®äœçœ®ã瀺ãã ïŒïŒïœïŒïŒã®å Žå ïŒïŒïœïŒïŒã®å Žå
ãåŒã
ãåŒã
ãŸãäžèšã®è¡šïŒã®åæäŸ21ã24ã«ã¿ãããã·ã¯
ããããµã³ãã·ã¯ããã³ã¿ã³ç°ã¯ãäžèšã®æ§é ã®
ïŒã®äœçœ®ã§ã¹ããçµåããŠããããšã瀺ãã
ããããµã³ãã·ã¯ããã³ã¿ã³ç°ã¯ãäžèšã®æ§é ã®
ïŒã®äœçœ®ã§ã¹ããçµåããŠããããšã瀺ãã
ãè¡šã
ãè¡šã
次ã«æ¬çºæãå®æœããéã®è£œå€äŸã®å
·äœäŸãå®
æœäŸïŒããã³ïŒã§è¿°ã¹ãã å®æœäŸïŒ é å€ ïŒâã¯ããâïŒâã¡ãã«âã¹ããâãã¯ããã³
âïŒïŒ4â²âã€ãããŸãªãžã³ã2â²ïŒ5â²âãžãªã³ 10g ã³ãŒã³ã¹ã¿ãŒã 20g ä¹³ç³ 75g ã«ã«ããã·ã¡ãã«ã»ã«ããŒã¹ã«ã«ã·ãŠã 20g ããªããã«ãããªãã³ 10g ã¿ã«ã¯ 10g 埮çµæ¶ã»ã«ããŒã¹ 55g åžžæ³ã«ãããã€ãŠãäžèšåæåãæ··åããé¡ç²
ç¶ãšããå§çž®æ圢ããŠïŒé 200mgã®é å€ãšããã å®æœäŸïŒ ã«ãã»ã«å€ ïŒâãã«ãªãâïŒâã¡ãã«âã¹ããâãã¯ãã
ã³âïŒïŒ4â²âã€ãããŸãªãžã³ã2â²ïŒ5â²âãžãªã³ 10g ä¹³ç³ 70g ããŠã¢ãã³ã·ãã³ãã³ 20g äžèšã®åŠæ¹ã«ãããåžžæ³ã«ãããã€ãŠïŒå100
mgã®ã«ãã»ã«å€ã調補ããã
æœäŸïŒããã³ïŒã§è¿°ã¹ãã å®æœäŸïŒ é å€ ïŒâã¯ããâïŒâã¡ãã«âã¹ããâãã¯ããã³
âïŒïŒ4â²âã€ãããŸãªãžã³ã2â²ïŒ5â²âãžãªã³ 10g ã³ãŒã³ã¹ã¿ãŒã 20g ä¹³ç³ 75g ã«ã«ããã·ã¡ãã«ã»ã«ããŒã¹ã«ã«ã·ãŠã 20g ããªããã«ãããªãã³ 10g ã¿ã«ã¯ 10g 埮çµæ¶ã»ã«ããŒã¹ 55g åžžæ³ã«ãããã€ãŠãäžèšåæåãæ··åããé¡ç²
ç¶ãšããå§çž®æ圢ããŠïŒé 200mgã®é å€ãšããã å®æœäŸïŒ ã«ãã»ã«å€ ïŒâãã«ãªãâïŒâã¡ãã«âã¹ããâãã¯ãã
ã³âïŒïŒ4â²âã€ãããŸãªãžã³ã2â²ïŒ5â²âãžãªã³ 10g ä¹³ç³ 70g ããŠã¢ãã³ã·ãã³ãã³ 20g äžèšã®åŠæ¹ã«ãããåžžæ³ã«ãããã€ãŠïŒå100
mgã®ã«ãã»ã«å€ã調補ããã
å³ïŒã¯ãã¬ã©ã¯ããŒã¹çœå
éã©ããã«ããã察
ç §ååç©ãšæ¬çºæååç©ã®çœå éã«å¯Ÿããå¹æã
瀺ãã°ã©ãã§ããã暪軞ã¯æ¥æ°ã瀺ãã瞊軞ã¯çœ
å éã®çºççã瀺ãã
ç §ååç©ãšæ¬çºæååç©ã®çœå éã«å¯Ÿããå¹æã
瀺ãã°ã©ãã§ããã暪軞ã¯æ¥æ°ã瀺ãã瞊軞ã¯çœ
å éã®çºççã瀺ãã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ äžè¬åŒ ïŒåŒäžX1ããã³X2ã¯åäžãŸãã¯ç°ãªã€ãŠãã
ããæ°ŽçŽ ååãããã²ã³ååãäœçŽã¢ã«ãã«åºã
ãŸãã¯äœçŽã¢ã«ã³ãã·åºãæå³ããã¯é žçŽ åå
ãŸãã¯ç¡«é»ååãæå³ããR1ããã³R2ã¯åäžãŸ
ãã¯ç°ãªã€ãŠããããæ°ŽçŽ ååãäœçŽã¢ã«ãã«
åºãããšãã«åºããŸãã¯äž¡è ãšãããã«çµåããŠ
ããççŽ ååãšã§ç°ã圢æãããäœããR1ãã
ã³R2ãåæã«æ°ŽçŽ ååã§ããå Žåã¯é€ããïœã¯
ïŒãŸãã¯ïŒã®æŽæ°ãæå³ãããïŒã§è¡šããããã
ãã³ãã€ã³èªå°äœããã³ãã®å¡©ãæå¹æåãšãã
ç³å°¿ç ã«ãšããªãæ ¢æ§çç¶ã»å䜵çç¶ã®æ²»çã»äº
é²å€ã ïŒ ååç©ããäžè¬åŒ ïŒåŒäžX1ããã³X2ã¯åäžãŸãã¯ç°ãªã€ãŠãã
ããæ°ŽçŽ ååãããã²ã³ååãäœçŽã¢ã«ãã«åºã
ãŸãã¯äœçŽã¢ã«ã³ãã·åºãæå³ããR1ããã³R2
ã¯åäžãŸãã¯ç°ãªã€ãŠããããæ°ŽçŽ ååãäœçŽã¢
ã«ãã«åºãããšãã«åºããŸãã¯äž¡è ãšãããã«çµ
åããŠããççŽ ååãšã§ç°ã圢æãããäœãã
R1ããã³R2ãåæã«æ°ŽçŽ ååã§ããå Žåã¯é€ãã
ïœã¯ïŒãŸãã¯ïŒã®æŽæ°ãæå³ãããïŒã§è¡šããã
ãååç©ããã³ãã®å¡©ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒ
é èšèŒã®ç³å°¿ç ã«ãšããªãæ ¢æ§çç¶ã»å䜵çç¶ã®
æ²»çã»äºé²å€ã ïŒ ååç©ããäžè¬åŒ ïŒåŒäžX1ããã³X2ã¯åäžãŸãã¯ç°ãªã€ãŠãã
ããæ°ŽçŽ ååãããã²ã³ååãäœçŽã¢ã«ãã«åºã
ãŸãã¯äœçŽã¢ã«ã³ãã·åºãæå³ããR1ããã³R2
ã¯åäžãŸãã¯ç°ãªã€ãŠããããæ°ŽçŽ ååãäœçŽã¢
ã«ãã«åºãããšãã«åºããŸãã¯äž¡è ãšãããã«çµ
åããŠããççŽ ååãšã§ç°ã圢æãããäœãã
R1ããã³R2ãåæã«æ°ŽçŽ ååã§ããå Žåã¯é€
ããïŒã§è¡šããããååç©ããã³ãã®å¡©ã§ããç¹
èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ç³å°¿ç ã«ãšããªãæ ¢æ§
çç¶ã»å䜵çç¶ã®æ²»çã»äºé²å€ã ïŒ ååç©ããïŒâãã«ãªãâïŒâã¡ãã«âã¹ã
ãâãã¯ããã³âïŒïŒ4ÂŽâã€ãããŸãªãžã³ãâ2â²ïŒ
5â²âãžãªã³ããã³ãã®å¡©ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬
ïŒé èšèŒã®ç³å°¿ç ã«ãšããªãæ ¢æ§çç¶ã»å䜵çç¶
ã®æ²»çã»äºé²å€ã ïŒ ååç©ããïŒâã¯ããâïŒâã¡ãã«âã¹ãã
âãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ
5â²âãžãªã³ããã³ãã®å¡©ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬
ïŒé èšèŒã®ç³å°¿ç ã«ãšããªãæ ¢æ§çç¶ã»å䜵çç¶
ã®æ²»çã»äºé²å€ã ïŒ ååç©ãïŒâã¯ããâïŒïŒïŒâãžã¡ãã«âã¹
ããâãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ
2â²ïŒ5â²âãžãªã³ããã³ãã®å¡©ã§ããç¹èš±è«æ±ã®ç¯
å²ç¬¬ïŒé èšèŒã®ç³å°¿ç ã«ãšããªãæ ¢æ§çç¶ã»å䜵
çç¶ã®æ²»çã»äºé²å€ã ïŒ ååç©ãïŒâãã«ãªãâïŒïŒïŒâãžã¡ãã«â
ã¹ããâãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ
2â²ïŒ5â²âãžãªã³ããã³ãã®å¡©ã§ããç¹èš±è«æ±ã®ç¯
å²ç¬¬ïŒé èšèŒã®ç³å°¿ç ã«ãšããªãæ ¢æ§çç¶ã»å䜵
çç¶ã®æ²»çã»äºé²å€ã ïŒ ååç©ãïŒïŒïŒâãžã¯ããâïŒïŒïŒâãžã¡ã
ã«âã¹ããâãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãž
ã³ãâ2â²ïŒ5â²âãžãªã³ããã³ãã®å¡©ã§ããç¹èš±è«
æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ç³å°¿ç ã«ãšããªãæ ¢æ§ç
ç¶ã»å䜵çç¶ã®æ²»çã»äºé²å€ã ïŒ ååç©ããïŒâã¯ããâïŒâã¡ãã«âã¹ãã
âããã³ãŸãã©ã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ
2â²ïŒ5â²âãžãªã³ããã³ãã®å¡©ã§ããç¹èš±è«æ±ã®ç¯
å²ç¬¬ïŒé èšèŒã®ç³å°¿ç ã«ãšããªãæ ¢æ§çç¶ã»å䜵
çç¶ã®æ²»çã»äºé²å€ã ïŒïŒ ååç©ããïŒâããã¢âïŒïŒïŒâãžã¡ãã«
âã¹ããâãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ã
â2â²ïŒ5â²âãžãªã³ããã³ãã®å¡©ã§ããç¹èš±è«æ±ã®
ç¯å²ç¬¬ïŒé èšèŒã®ç³å°¿ç ã«ãšããªãæ ¢æ§çç¶ã»å
䜵çç¶ã®æ²»çã»äºé²å€ã ïŒïŒ ååç©ããïŒïŒïŒâãžã¯ããâïŒâã¡ãã«
âã¹ããâãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ã
â2â²ïŒ5â²âãžãªã³ããã³ãã®å¡©ã§ããç¹èš±è«æ±ã®
ç¯å²ç¬¬ïŒé èšèŒã®ç³å°¿ç ã«ãšããªãæ ¢æ§çç¶ã»å
䜵çç¶ã®æ²»çã»äºé²å€ã ïŒïŒ ååç©ããïŒâã¯ããâïŒâã¡ãã«âã¹ã
ãâãã¯ããã³âïŒïŒ4â²âã€ãããŸãªãžã³ãâ2â²ïŒ
5â²âãžãªã³ããã³ãã®å¡©ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬
ïŒé èšèŒã®ç³å°¿ç ã«ãšããªãæ ¢æ§çç¶ã»å䜵çç¶
ã®æ²»çã»äºé²å€ã ïŒïŒ ç³å°¿ç ã«ãšããªãæ ¢æ§çç¶ã»å䜵çç¶ãç³
å°¿ç æ§çœå éã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®
ç³å°¿ç æ§çœå éã®æ²»çã»äºé²å€ã ïŒïŒ ç³å°¿ç ã«ãšããªãæ ¢æ§çç¶ã»å䜵çç¶ãç³
å°¿ç æ§ç¥çµé害ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒ
ã®ç³å°¿ç æ§ç¥çµé害ã®æ²»çã»äºé²å€ã
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP608582A JPS58213717A (ja) | 1982-01-20 | 1982-01-20 | ããã³ãã€ã³èªå°äœãå«æããæ²»ççšè¬å€ |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP608582A JPS58213717A (ja) | 1982-01-20 | 1982-01-20 | ããã³ãã€ã³èªå°äœãå«æããæ²»ççšè¬å€ |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS58213717A JPS58213717A (ja) | 1983-12-12 |
JPH0451527B2 true JPH0451527B2 (ja) | 1992-08-19 |
Family
ID=11628700
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP608582A Granted JPS58213717A (ja) | 1982-01-20 | 1982-01-20 | ããã³ãã€ã³èªå°äœãå«æããæ²»ççšè¬å€ |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS58213717A (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61200991A (ja) * | 1985-03-04 | 1986-09-05 | Sanwa Kagaku Kenkyusho:Kk | ã¹ããâïŒâãããã¢ãŸãªãžã³ååç©ããã®è£œæ³åã³ãããæå¹æåãšããç³å°¿ç å䜵çã®äºé²åã³æ²»çå€ |
JPS6357588A (ja) * | 1986-08-28 | 1988-03-12 | Sanwa Kagaku Kenkyusho Co Ltd | ããã³ãã€ã³èªå°äœããã®å¡©äžŠã³ã«è©²ååç©ãæå¹æåãšããç³å°¿ç å䜵çã®äºé²åã³æ²»çå€ |
ATE96668T1 (de) * | 1989-02-22 | 1993-11-15 | Sanwa Kagaku Kenkyusho Co | Pharmazeutische zusammensetzung, die ein hydantoin-derivat enthaelt. |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5353653A (en) * | 1976-10-18 | 1978-05-16 | Pfizer | Hydantoin derivatives medicines |
-
1982
- 1982-01-20 JP JP608582A patent/JPS58213717A/ja active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5353653A (en) * | 1976-10-18 | 1978-05-16 | Pfizer | Hydantoin derivatives medicines |
Also Published As
Publication number | Publication date |
---|---|
JPS58213717A (ja) | 1983-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4874869A (en) | Hydantoin derivatives and medicines containing the same | |
CA1088073A (en) | Hydantoin therapeutic agents | |
US4210667A (en) | Pharmaceutical preparations containing coumarin carboxylic acid derivatives | |
CS199690B2 (cs) | Způsob vÜroby spiro-hydantoinovÜch derivátů | |
EP0030861B1 (en) | Isoquinoline acetic acids and pharmaceutical compositions thereof | |
JPS5940388B2 (ja) | ããã³ãã€ã³èªå°äœæ²»çå€ | |
JPS6144868B2 (ja) | ||
EP0008229B1 (en) | Spiro-furanohydantoin derivatives, process for their preparation and pharmaceutical compositions containing them | |
JPH05213940A (ja) | æ°èŠãªãã³ãŸãã©ã³èªå°äœ | |
US4134991A (en) | Derivatives of 2-(3-phenyl-2-aminopropionyloxy)-acetic acid | |
EP0718289B1 (en) | Novel parabanic acid derivatives as aldose reductase inhibitors | |
JPH0451527B2 (ja) | ||
JPS62252774A (ja) | ãã¿ã©ãžã³èªå°äœããã³ãã®è£œé æ³ | |
EP0718290B1 (en) | Carboxyalkyl heterocyclic derivatives | |
KR20000017411A (ko) | ì¡°íŽë ì€ííž ìŒìí묌ì ëì§ìŽì첎 | |
JPS5840959B2 (ja) | ã¢ã«ãâã¹éå é µçŽ é»å®³å€ã¹ããâãããªã«ããã³ãã€ã³èªå°äœ | |
IE57520B1 (en) | Imidazolidinedione derivatives | |
KR870001267B1 (ko) | 5-(2-ììœìíë)í°ìì¡ž 늬ëëìšì ì ì¡°ë°©ë² | |
US4177282A (en) | Hydantoin therapeutic agents | |
US4226860A (en) | Spiroindolones | |
EP0193855B1 (en) | Hydantoin derivatives, processes for preparing them and pharmaceutical compositions containing them | |
US4464385A (en) | Treatment of diabetic complications with hydantoins | |
EP0159143A1 (en) | Spiro-indenes and spiro-1,2-dihydro-naphthalenes for treatment of diabetic complications | |
JPS63280080A (ja) | 眮æããããµãªã«âã€ãããŸãªãžã³âïŒïŒïŒâãžãªã³ | |
JPH04270273A (ja) | ãã¢ãŸãªãžã³âïŒïŒïŒâãžãªã³èªå°äœãšãã®å¡©åã³ãã®è£œé æ³ |